CA2178729A1 - Compounds and methods for site-directed mutations in eukaryotic cells - Google Patents

Compounds and methods for site-directed mutations in eukaryotic cells

Info

Publication number
CA2178729A1
CA2178729A1 CA002178729A CA2178729A CA2178729A1 CA 2178729 A1 CA2178729 A1 CA 2178729A1 CA 002178729 A CA002178729 A CA 002178729A CA 2178729 A CA2178729 A CA 2178729A CA 2178729 A1 CA2178729 A1 CA 2178729A1
Authority
CA
Canada
Prior art keywords
duplex
nucleic acid
region
chimeric
hybrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002178729A
Other languages
English (en)
French (fr)
Inventor
Eric B. Kmiec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2178729A1 publication Critical patent/CA2178729A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002178729A 1993-12-09 1994-12-09 Compounds and methods for site-directed mutations in eukaryotic cells Abandoned CA2178729A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16430393A 1993-12-09 1993-12-09
US164,303 1993-12-09

Publications (1)

Publication Number Publication Date
CA2178729A1 true CA2178729A1 (en) 1995-06-15

Family

ID=22593886

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002178729A Abandoned CA2178729A1 (en) 1993-12-09 1994-12-09 Compounds and methods for site-directed mutations in eukaryotic cells

Country Status (15)

Country Link
US (3) US5565350A (zh)
EP (1) EP0733059B1 (zh)
JP (1) JP3585238B2 (zh)
KR (1) KR100386337B1 (zh)
CN (2) CN1048254C (zh)
AT (1) ATE196311T1 (zh)
AU (1) AU691550B2 (zh)
CA (1) CA2178729A1 (zh)
DE (2) DE69425903T2 (zh)
DK (1) DK0733059T3 (zh)
ES (1) ES2149962T3 (zh)
GR (1) GR3034988T3 (zh)
NZ (1) NZ278490A (zh)
PT (1) PT733059E (zh)
WO (1) WO1995015972A1 (zh)

Families Citing this family (801)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475795B1 (en) * 1991-07-03 2002-11-05 Meditech Research, Ltd. Use of hyaluronan in gene therapy
US6335434B1 (en) 1998-06-16 2002-01-01 Isis Pharmaceuticals, Inc., Nucleosidic and non-nucleosidic folate conjugates
US8153602B1 (en) 1991-11-19 2012-04-10 Isis Pharmaceuticals, Inc. Composition and methods for the pulmonary delivery of nucleic acids
US20020108136A1 (en) * 1997-03-21 2002-08-08 Sri Transgenic animals produced by homologous sequence targeting
US5523389A (en) * 1992-09-29 1996-06-04 Isis Pharmaceuticals, Inc. Inhibitors of human immunodeficiency virus
CA2170869C (en) 1993-09-03 1999-09-14 Phillip Dan Cook Amine-derivatized nucleosides and oligonucleosides
US6420549B1 (en) 1995-06-06 2002-07-16 Isis Pharmaceuticals, Inc. Oligonucleotide analogs having modified dimers
US5760012A (en) * 1996-05-01 1998-06-02 Thomas Jefferson University Methods and compounds for curing diseases caused by mutations
US5731181A (en) * 1996-06-17 1998-03-24 Thomas Jefferson University Chimeric mutational vectors having non-natural nucleotides
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US20030044941A1 (en) 1996-06-06 2003-03-06 Crooke Stanley T. Human RNase III and compositions and uses thereof
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US7875733B2 (en) 2003-09-18 2011-01-25 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
DE69823324T2 (de) * 1997-03-03 2005-02-24 Applera Corp., Foster City Verbesserte chimäre oligonukleotidvektoren
US5948653A (en) * 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
US6524613B1 (en) 1997-04-30 2003-02-25 Regents Of The University Of Minnesota Hepatocellular chimeraplasty
GB9711015D0 (en) * 1997-05-28 1997-07-23 Zeneca Ltd Improvements in or relating to organic compounds
EP1012331B1 (en) 1997-07-01 2006-03-29 Isis Pharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
KR20010022652A (ko) * 1997-08-05 2001-03-26 키메라젠, 인크. 식물에서 국소적인 유전자변형을 유발하기 위한 혼성 이중나선올리고뉴클레오티드의 용도
US7102055B1 (en) 1997-11-18 2006-09-05 Pioneer Hi-Bred International, Inc. Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
US6187994B1 (en) 1997-11-18 2001-02-13 Pioneer Hi-Bred International, Inc. Compositions and methods for genetic modification of plants
AU1526199A (en) 1997-11-18 1999-06-07 Pioneer Hi-Bred International, Inc. Targeted manipulation of herbicide-resistance genes in plants
EP0945507A1 (de) * 1998-03-27 1999-09-29 Boehringer Mannheim Gmbh Tumorspezifische Expressionskontrollregion und deren Verwendung
US20040186071A1 (en) 1998-04-13 2004-09-23 Bennett C. Frank Antisense modulation of CD40 expression
US6010907A (en) 1998-05-12 2000-01-04 Kimeragen, Inc. Eukaryotic use of non-chimeric mutational vectors
US6004804A (en) 1998-05-12 1999-12-21 Kimeragen, Inc. Non-chimeric mutational vectors
EP1080103A4 (en) * 1998-05-21 2003-07-02 Isis Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR NON-PARENTERAL ADMINISTRATION OF OLIGONUCLEOTIDES
WO1999060167A1 (en) 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
US6693185B2 (en) 1998-07-17 2004-02-17 Bayer Bioscience N.V. Methods and means to modulate programmed cell death in eukaryotic cells
DE19836098A1 (de) 1998-07-31 2000-02-03 Hoechst Schering Agrevo Gmbh Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke
JP2003523166A (ja) 1998-09-29 2003-08-05 ガミダ セル リミテッド 幹細胞および前駆細胞の増殖と分化を制御する方法
US6077709A (en) 1998-09-29 2000-06-20 Isis Pharmaceuticals Inc. Antisense modulation of Survivin expression
AU773808B2 (en) 1998-11-09 2004-06-10 Bayer Cropscience Aktiengesellschaft Nucleic acid molecules from rice and their use for the production of modified starch
US6438561B1 (en) * 1998-11-19 2002-08-20 Navigation Technologies Corp. Method and system for using real-time traffic broadcasts with navigation systems
US6917882B2 (en) * 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
AU2415200A (en) * 1999-01-18 2000-08-01 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US20030054390A1 (en) * 1999-01-19 2003-03-20 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US20070065838A1 (en) * 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
EP2253704B1 (en) 1999-01-19 2015-08-19 Codexis Mayflower Holdings, LLC Oligonucleotide mediated nucleic acid recombination
US6127124A (en) * 1999-01-20 2000-10-03 Isis Pharmaceuticals, Inc. Fluorescence based nuclease assay
CA2368655A1 (en) * 1999-04-08 2000-10-19 Gregory M. Glenn Dry formulation for transcutaneous immunization
US7098192B2 (en) 1999-04-08 2006-08-29 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of STAT3 expression
EP2055779A3 (en) 1999-05-07 2009-08-12 E.I. Dupont De Nemours And Company Auxin transport proteins
US6656730B1 (en) 1999-06-15 2003-12-02 Isis Pharmaceuticals, Inc. Oligonucleotides conjugated to protein-binding drugs
US6271360B1 (en) * 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
WO2001025460A2 (en) * 1999-10-07 2001-04-12 Valigen, Inc. Compositions and methods for plant genetic modification
AR025996A1 (es) 1999-10-07 2002-12-26 Valigen Us Inc Plantas no transgenicas resistentes a los herbicidas.
US7430477B2 (en) * 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US20030190644A1 (en) 1999-10-13 2003-10-09 Andreas Braun Methods for generating databases and databases for identifying polymorphic genetic markers
AU1777301A (en) * 1999-11-19 2001-05-30 Hematech, Llc Production of ungulates, preferably bovines that produce human immunoglobulins
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
US7074983B2 (en) * 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
US7820878B2 (en) * 1999-11-19 2010-10-26 Kyowa Hakko Kirin Co., Ltd. Production of ungulates, preferably bovines that produce human immunoglobulins
US6261840B1 (en) 2000-01-18 2001-07-17 Isis Pharmaceuticals, Inc. Antisense modulation of PTP1B expression
US20020055479A1 (en) 2000-01-18 2002-05-09 Cowsert Lex M. Antisense modulation of PTP1B expression
US20060134629A1 (en) * 2000-03-20 2006-06-22 Link Charles J Methods and compositions for elucidating protein expression profiles in cells
US6897020B2 (en) * 2000-03-20 2005-05-24 Newlink Genetics Inc. Methods and compositions for elucidating relative protein expression levels in cells
KR20030003240A (ko) * 2000-03-27 2003-01-09 유니버시티 오브 델라웨어 개질된 단일 가닥 올리고뉴클레오티드를 이용한 표적염색체 게놈 변경법
US6936467B2 (en) * 2000-03-27 2005-08-30 University Of Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
EP1284985A2 (en) * 2000-05-17 2003-02-26 University Of Delaware Plant gene targeting using oligonucleotides
US6656700B2 (en) 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
US6686188B2 (en) * 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
WO2001094610A2 (en) * 2000-06-05 2001-12-13 Thomas Jefferson University Binary hybrid mutational vectors
US7468475B2 (en) 2000-06-16 2008-12-23 Schmuelling Thomas Method for modifying plant morphology, biochemistry and physiology
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
AU2001279069A1 (en) * 2000-07-27 2002-02-13 University Of Delaware Methods for enhancing targeted gene alteration using oligonucleotides
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
WO2002026967A2 (en) * 2000-09-25 2002-04-04 Thomas Jefferson University Targeted gene correction by single-stranded oligodeoxynucleotides
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
US7560622B2 (en) 2000-10-06 2009-07-14 Pioneer Hi-Bred International, Inc. Methods and compositions relating to the generation of partially transgenic organisms
US20020142397A1 (en) * 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
US7491534B2 (en) 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
JP4420604B2 (ja) * 2000-12-22 2010-02-24 協和発酵キリン株式会社 再プログラムしたドナークロマチンまたはドナー細胞を用いて哺乳類をクローニングする方法
WO2002059337A1 (en) * 2001-01-26 2002-08-01 Georgetown University School Of Medicine Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
WO2002079495A2 (en) * 2001-03-27 2002-10-10 University Of Delaware Genomics applications for modified oligonucleotides
AU2002305151A1 (en) * 2001-04-06 2002-10-21 Georgetown University Gene scc-112 and diagnostic and therapeutic uses thereof
WO2002081640A2 (en) * 2001-04-06 2002-10-17 Georgetown University Gene shinc-1 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) * 2001-04-06 2002-10-21 Georgetown University Gene brcc2 and diagnostic and therapeutic uses thereof
WO2002081642A2 (en) 2001-04-06 2002-10-17 Georgetown University Gene brcc-3 and diagnostic and therapeutic uses thereof
US20040063922A1 (en) * 2001-04-17 2004-04-01 Conrad Charles A. Methods and compositions for catalytic DNA exchange in a sequence specific manner
US20030045830A1 (en) * 2001-04-17 2003-03-06 De Bizemont Therese Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
US7053195B1 (en) 2001-06-12 2006-05-30 Syngenta Participatious Ag Locked nucleic acid containing heteropolymers and related methods
US7803915B2 (en) 2001-06-20 2010-09-28 Genentech, Inc. Antibody compositions for the diagnosis and treatment of tumor
EP1409549A4 (en) 2001-06-20 2007-10-24 Genentech Inc COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMORS
EP1404698A4 (en) 2001-06-21 2004-12-22 Isis Pharmaceuticals Inc ANTI-SENSE MODULATION OF SOLUBLE SUPEROXIDE DISMUTASE 1 EXPRESSION
EP1925672A1 (en) 2001-06-22 2008-05-28 Syngeta Participations AG Abiotic stress responsive polynucleotides and polypeptides
US7425545B2 (en) 2001-07-25 2008-09-16 Isis Pharmaceuticals, Inc. Modulation of C-reactive protein expression
US6964950B2 (en) 2001-07-25 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of C-reactive protein expression
US20030096772A1 (en) 2001-07-30 2003-05-22 Crooke Rosanne M. Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression
US7407943B2 (en) 2001-08-01 2008-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein B expression
US7227014B2 (en) 2001-08-07 2007-06-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein (a) expression
EP1423537A4 (en) * 2001-08-07 2006-11-29 Univ Delaware COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING HUNTINGTON'S DISEASE
AU2002322435A1 (en) * 2001-08-09 2003-02-24 Cibus Genetics Non-transgenic herbicide resistant plants
US7456335B2 (en) * 2001-09-03 2008-11-25 Basf Plant Science Gmbh Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
ATE509120T1 (de) 2001-09-18 2011-05-15 Carnegie Inst Of Washington Fusionsproteine zur detektion von analyten
EP2143438B1 (en) 2001-09-18 2011-07-13 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumors
US20030207327A1 (en) * 2001-09-27 2003-11-06 Kmiec Eric B. Coisogenic eukaryotic cell collections
US7112405B2 (en) * 2001-09-27 2006-09-26 University Of Delaware Compositions and methods for enhancing oligonucleotide-mediated gene alteration
EP1437936A4 (en) 2001-09-27 2005-10-12 Pioneer Hi Bred Int PHYTATE POLYNUCLEOTIDES AND METHOD FOR THEIR USE
US7468244B2 (en) * 2001-09-27 2008-12-23 University Of Delaware Polymorphism detection and separation
US6750019B2 (en) 2001-10-09 2004-06-15 Isis Pharmaceuticals, Inc. Antisense modulation of insulin-like growth factor binding protein 5 expression
EP2270231A3 (en) 2001-10-09 2011-04-27 ISIS Pharmaceuticals, Inc. Antisense modulation of insulin-like growth factor binding protein 5 expression
US6965025B2 (en) 2001-12-10 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of connective tissue growth factor expression
AU2002367318B2 (en) 2002-01-02 2007-07-12 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
WO2003062404A1 (en) 2002-01-25 2003-07-31 Gamida-Cell Ltd. Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
US20040014956A1 (en) 2002-02-01 2004-01-22 Sequitur, Inc. Double-stranded oligonucleotides
US20030166282A1 (en) 2002-02-01 2003-09-04 David Brown High potency siRNAS for reducing the expression of target genes
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
US7135326B2 (en) * 2002-02-07 2006-11-14 E. I. Du Pont De Nemours And Company UDP-glucosyltransferases
AU2003211128A1 (en) * 2002-02-20 2003-09-09 American Integrated Biologics, Inc. Transgenic production in saliva
IL163875A0 (en) * 2002-03-07 2005-12-18 Univ Delaware Methods, compositions, and kits for enhancing oli gonucleotide mediated nucleic acid sequence alteration using compositions comprising a histone de
EP1572927A4 (en) 2002-04-08 2007-10-17 Pioneer Hi Bred Int REINFORCED EXTRACTION OF SILK UNDER STRESS
US7244565B2 (en) * 2002-04-10 2007-07-17 Georgetown University Gene shinc-3 and diagnostic and therapeutic uses thereof
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
KR20040101502A (ko) 2002-04-16 2004-12-02 제넨테크, 인크. 종양의 진단 및 치료 방법 및 이를 위한 조성물
US7432342B2 (en) 2002-05-03 2008-10-07 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof and related documents
WO2003095655A2 (de) 2002-05-08 2003-11-20 Basf Plant Science Gmbh Verfahren zum erhöhen des ölgehaltes in pflanzen
US20030228317A1 (en) * 2002-05-22 2003-12-11 Prafulla Gokhale Gene BRCC-1 and diagnostic and therapeutic uses thereof
US7199107B2 (en) 2002-05-23 2007-04-03 Isis Pharmaceuticals, Inc. Antisense modulation of kinesin-like 1 expression
US20030228558A1 (en) * 2002-06-11 2003-12-11 Bloom William Dennis Method of training brokers in a multi-level marketing business
AU2003231912A1 (en) * 2002-06-12 2003-12-31 Tel Aviv Medical Center Research Development Fund Methods of detecting and treating prostate cancer
US20060258602A1 (en) * 2002-09-20 2006-11-16 Yukio Ando Site-specific gene conversion promoter and gene therapeutic
AU2003278957A1 (en) 2002-09-26 2004-04-23 Amgen, Inc. Modulation of forkhead box o1a expression
WO2004033708A2 (en) * 2002-10-07 2004-04-22 University Of Delaware Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration
US9150605B2 (en) * 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
WO2004042029A2 (en) 2002-11-05 2004-05-21 Isis Pharmaceuticals, Inc. Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use
US9150606B2 (en) 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
CA2504720C (en) 2002-11-05 2013-12-24 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
CA2502490A1 (en) * 2002-11-08 2004-05-27 Hematech, Llc Transgenic ungulates having reduced prion protein activity and uses thereof
SI1569695T1 (sl) 2002-11-13 2013-08-30 Genzyme Corporation Protismiselna modulacija ekspresije apolipoproteina B
EP1569695B1 (en) 2002-11-13 2013-05-15 Genzyme Corporation Antisense modulation of apolipoprotein b expression
EP1572971B1 (en) 2002-11-15 2009-09-30 Morphotek Inc. Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
DE60323149D1 (de) 2002-12-19 2008-10-02 Bayer Cropscience Gmbh Pflanzenzellen und pflanzen, die eine stärke mit erhöhter endviskosität synthetisieren
ES2400033T3 (es) 2003-02-11 2013-04-05 Antisense Therapeutics Ltd Modulación de la expresión del receptor del factor de crecimiento I similar a la insulina
BRPI0407514A (pt) 2003-02-17 2006-02-14 Metanomics Gmbh método para preparar um organismo não humano, polinucleotìdeo, método para preparar um vetor, vetor, célula hospedeira, polipeptìdeo, anticorpo, ácido polinucléico de anti-sentido, método para preparar uma planta, célula vegetal, tecido vegetal transgênicos, célula de um animal útil, animal útil ou um microorganismo transgênico organismo não humano, microorganismo transgênico, rendimento ou um material de propagação de uma planta ou de um animal útil, biomassa de um microorganismo, método para preparar produtos quìmicos finos, e, uso de polipeptìdeo
US7803781B2 (en) 2003-02-28 2010-09-28 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
US20040185559A1 (en) 2003-03-21 2004-09-23 Isis Pharmaceuticals Inc. Modulation of diacylglycerol acyltransferase 1 expression
WO2004087902A2 (de) 2003-03-31 2004-10-14 University Of Bristol Neue pflanzliche acyltransferasen spezifisch für langkettige mehrfach ungesättigte fettsäuren
US20040205840A1 (en) * 2003-04-11 2004-10-14 Pioneer Hi-Bred International, Inc. Method for reducing gene expression
WO2005014828A2 (en) 2003-08-01 2005-02-17 Basf Plant Science Gmbh Process for the production of fine chemicals in plants
BRPI0409442A (pt) 2003-04-15 2006-04-18 Basf Plant Science Gmbh célula vegetal transformada, planta transgênica, semente, molécula de ácido nucleico isolado, construção de ácido nucleico, vetor, célula hospedeira, proteìna relacionada com a tensão (srp) isolada, métodos de produzir uma planta transgênica com atividade metabólica alterada em comparação com uma célula vegetal do tipo selvagem não transformada correspondente e de modificar a toleráncia à tensão de uma planta, uso de um ácido nucleico que codifica srp e/ou de atividade metabólica alterada, célula vegetal, e, planta
US7598227B2 (en) 2003-04-16 2009-10-06 Isis Pharmaceuticals Inc. Modulation of apolipoprotein C-III expression
US7399853B2 (en) 2003-04-28 2008-07-15 Isis Pharmaceuticals Modulation of glucagon receptor expression
US7541344B2 (en) 2003-06-03 2009-06-02 Eli Lilly And Company Modulation of survivin expression
EP1644475A4 (en) * 2003-06-20 2009-06-03 Isis Pharmaceuticals Inc DOUBLE-STRAND COMPOSITIONS WITH A 3'-ENDO-MODIFIED STRING FOR USE IN GENE MODULATION
EP1648914A4 (en) 2003-07-31 2009-12-16 Regulus Therapeutics Inc OLIGOMERIC COMPOUNDS AND COMPOSITIONS USEFUL FOR MODULATING SMALL NON-CODING RNA
MX342029B (es) 2003-08-01 2016-09-12 Basf Plant Science Gmbh * Metodo para la produccion de acidos grasos poli - insaturados en organismos transgenicos.
CN1832961B (zh) 2003-08-11 2011-04-06 植物育种农业研究所有限公司 真菌抗性植物和它们的用途
US7825235B2 (en) 2003-08-18 2010-11-02 Isis Pharmaceuticals, Inc. Modulation of diacylglycerol acyltransferase 2 expression
US20050053981A1 (en) 2003-09-09 2005-03-10 Swayze Eric E. Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
CN100558893C (zh) 2003-09-18 2009-11-11 Isis药物公司 eIF4E表达的调节
SI1678194T1 (sl) 2003-10-10 2014-02-28 Alchemia Oncology Pty Limited Modulacija sinteze hialuronana in degradacija pri zdravljenju bolezni
WO2005040428A2 (en) 2003-10-23 2005-05-06 Illumigen Biosciences, Inc. Detection of mutations in a gene associated with resistance to viral infection, oas1
US20050191653A1 (en) 2003-11-03 2005-09-01 Freier Susan M. Modulation of SGLT2 expression
AU2004291141B2 (en) 2003-11-17 2009-06-11 Genentech, Inc. Compositions and methods for the treatment of tumor of hematopoietic origin
US20050120397A1 (en) * 2003-11-24 2005-06-02 Hermann Steller Compounds and methods for regulation of spermatid differentiation
EP1694849B1 (en) 2003-12-17 2011-09-14 CropDesign N.V. Plants having modified growth characteristics and method for making the same
WO2005062923A2 (en) * 2003-12-24 2005-07-14 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
US7741070B2 (en) 2003-12-24 2010-06-22 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
US7608699B2 (en) * 2003-12-29 2009-10-27 Rockefeller University Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof
US20050164271A1 (en) 2004-01-20 2005-07-28 Sanjay Bhanot Modulation of glucocorticoid receptor expression
US7468431B2 (en) 2004-01-22 2008-12-23 Isis Pharmaceuticals, Inc. Modulation of eIF4E-BP2 expression
US7208474B2 (en) 2004-02-25 2007-04-24 Pioneer Hi-Bred International, Inc. Bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
ES2421440T3 (es) 2004-02-27 2013-09-02 Basf Plant Science Gmbh Método para preparar ácidos grasos poliinsaturados en plantas transgénicas
EP1720988B1 (de) 2004-02-27 2011-10-12 BASF Plant Science GmbH Verfahren zur herstellung von ungesättigten omega-3-fettsäuren in transgenen organismen
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
WO2005089268A2 (en) * 2004-03-15 2005-09-29 Isis Pharmaceuticals, Inc. Compositions and methods for optimizing cleavage of rna by rnase h
WO2005094370A2 (en) * 2004-03-29 2005-10-13 The General Hospital Corporation Oligonucleotide complex compositions and methods of use as gene alteration tools
EP2540734B1 (en) 2004-04-05 2016-03-30 Alnylam Pharmaceuticals, Inc. Process and reagents for oligonucleotide synthesis and purification
US20050244869A1 (en) 2004-04-05 2005-11-03 Brown-Driver Vickie L Modulation of transthyretin expression
JP2007533328A (ja) 2004-04-22 2007-11-22 キリンホールディングス株式会社 トランスジェニック動物及びその用途
US20070072815A1 (en) * 2004-05-04 2007-03-29 Kmiec Eric B Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
US7825293B2 (en) 2004-05-28 2010-11-02 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
CA2735315A1 (en) 2004-06-09 2005-12-29 Pioneer Hi-Bred International, Inc. Plastid transit peptides
WO2006069610A2 (en) 2004-07-02 2006-07-06 Metanomics Gmbh Process for the production of fine chemicals
US8680062B2 (en) 2004-07-06 2014-03-25 Deliversir Ltd. System for delivering therapeutic agents into living cells and cells nuclei
EP2439211A1 (en) 2004-07-12 2012-04-11 CropDesign N.V. Plants having improved growth characteristics and method for making the same
EP1774004B1 (en) 2004-07-31 2013-07-10 Metanomics GmbH Preparation of organisms with faster growth and/or higher yield
EP2997980B1 (en) 2004-08-10 2017-12-20 Kastle Therapeutics, LLC Methods for modulating lipoprotein and cholesterol levels in humans
BRPI0514478A (pt) 2004-08-16 2008-06-17 Cropdesign Nv método para melhorar caracterìsticas de crescimento de plantas, plantas, construção, método para a produção de uma planta transgênica, planta transgênica, partes coletáveis, e, usos de um ácido nucleico/gene codificando proteìna de ligação de rna ou variante do mesmo ou uso de uma proteìna de ligação de rna ou homólogo da mesma, de um rbp1 ou variante do mesmo ou uso de um polipeptìdeo rbp1 ou homólogo do mesmo e de uma proteìna de ligação de rna ou variante da mesma ou uso de um rbp1 ou variante do mesmo
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
EP1799812A4 (en) 2004-09-16 2009-09-09 Gamida Cell Ltd EX VIVO CULTIVATION METHODS OF STEM CELLS AND PRECURSOR BY CO-CULTURE WITH MESENCHYMAL CELLS
WO2006034348A2 (en) 2004-09-17 2006-03-30 Isis Pharmaceuticals, Inc. Enhanced antisense oligonucleotides
CA2579800A1 (en) 2004-09-24 2006-03-30 Basf Plant Science Gmbh Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
US8765700B2 (en) 2004-10-20 2014-07-01 Antisense Therapeutics Ltd. Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions
DE602005025669D1 (de) 2004-10-29 2011-02-10 Cropdesign Nv Pflanzen mit veränderten wachstumseigenschaften und verfahren zu deren herstellung
EP2096177A3 (en) 2004-12-17 2010-01-13 Metanomics GmbH Process for the production of lutein
AR051866A1 (es) 2004-12-24 2007-02-14 Cropdesign Nv Plantas con aumento del rendimiento y metodo de prepracion
WO2006071219A1 (en) 2004-12-28 2006-07-06 Pioneer Hi-Bred International, Inc. Improved grain quality through altered expression of seed proteins
EP2298920A1 (en) 2005-01-27 2011-03-23 CropDesign N.V. Plants having increased yield and a method for making the same
WO2006091194A1 (en) 2005-02-23 2006-08-31 North Carolina State University Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
EP2573188A2 (en) 2005-03-02 2013-03-27 Metanomics GmbH Process for the production of fine chemicals
EP2194140A2 (en) 2005-03-02 2010-06-09 Metanomics GmbH Process for the production of fine chemicals
EP2166100B1 (en) 2005-03-08 2012-07-18 BASF Plant Science GmbH Expression enhancing intron sequences
US20060281680A1 (en) 2005-03-10 2006-12-14 Genentech, Inc. Methods and compositions for modulating vascular integrity
DE102005013779A1 (de) 2005-03-22 2006-09-28 Basf Plant Science Gmbh Verfahren zur Herstellung von mehrfach ungesättigten C20- und C22-Fettsäuren mit mindestens vier Doppelbindungen in transgenen Pflanzen
EP1707632A1 (de) 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylierte waxy-Kartoffelstärke
CA2604807C (en) 2005-04-19 2018-06-12 Basf Plant Science Gmbh Improved methods controlling gene expression
EP1879626A4 (en) 2005-04-19 2011-03-23 Massachusetts Inst Technology AMPHIPHILIC POLYMERS AND METHODS OF USE
US20070011752A1 (en) * 2005-05-06 2007-01-11 American Integrated Biologics, Inc. Production of human proteins in transgenic animal saliva
WO2006127310A2 (en) 2005-05-25 2006-11-30 Pioneer Hi-Bred International, Inc. Methods for improving crop plant architecture and yield
EP1891141B1 (en) 2005-05-31 2016-11-16 Ecole Polytechnique Fédérale de Lausanne (EPFL) Triblock copolymers for cytoplasmic delivery of gene-based drugs
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
DE602006019588D1 (de) 2005-06-23 2011-02-24 Basf Plant Science Gmbh Verbesserte verfahren zur herstellung stabil transformierter und fruchtbarer buntmais-pflanzen
CN101258246B (zh) 2005-07-06 2012-09-05 克罗普迪塞恩股份有限公司 Ste20样基因表达对植物产率的提高
DE102005038036A1 (de) 2005-08-09 2007-02-15 Basf Plant Science Gmbh Verfahren zur Herstellung von Arachidonsäure und/oder Eicosapentaensäure in transgenen Nutzpflanzen
CN101365794A (zh) 2005-08-12 2009-02-11 巴斯福植物科学有限公司 编码与非生物性胁迫应答相关的蛋白质的核酸序列和具有增加的环境胁迫耐受性的植物细胞及植物
US7842856B2 (en) 2005-08-25 2010-11-30 The Board Of Trustees Of The University Of Illinois Herbicide resistance gene, compositions and methods
EP1931788A2 (en) 2005-09-15 2008-06-18 CropDesign N.V. Plants having increased yield and method for making the same
CN101268194A (zh) 2005-09-20 2008-09-17 巴斯福植物科学有限公司 使用ta-siRNA调控基因表达的方法
GB2431158A (en) 2005-10-13 2007-04-18 Rothamsted Res Ltd Process for the production of arachidonic and/or eicosapentaenoic acid
US8853492B2 (en) 2005-11-07 2014-10-07 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
EP1948807B1 (en) 2005-11-07 2015-09-30 CropDesign N.V. Plants having improved growth characteristics and a method for making the same
EP1948682A1 (en) 2005-11-08 2008-07-30 CropDesign N.V. Plants having improved growth characteristics and a method for making the same
CA2628505A1 (en) 2005-11-08 2007-05-18 Basf Plant Science Gmbh Use of armadillo repeat (arm1) polynucleotides for obtaining resistance to pathogens in plants
JP2009515522A (ja) 2005-11-10 2009-04-16 パイオニア ハイ−ブレッド インターナショナル, インコーポレイテッド Dof(dnabindingwithonefinger)配列および使用方法
US20070199096A1 (en) 2005-11-14 2007-08-23 E.I. Du Pont De Nemours And Company Compositions and Methods for Altering Alpha- and Beta-Tocotrienol Content
AU2006318194B2 (en) 2005-11-21 2012-08-09 Isis Pharmaceuticals, Inc. Modulation of eiF4E-BP2 expression
US7723574B2 (en) 2005-11-24 2010-05-25 Basf Plant Science Gmbh Process for the production of Δ5-unsaturated fatty acids in transgenic organisms
AU2006316537A1 (en) * 2005-11-24 2007-05-31 Basf Se Chimeric keratin-binding effector proteins
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
EP2166106B1 (en) 2005-12-01 2015-02-25 CropDesign N.V. Plants having improved growth characteristics and methods for making the same
JP2009521213A (ja) 2005-12-24 2009-06-04 ティーガスク デイリー プロダクツ リサーチ センター トランス−10,シス−12オクタデカジエン酸を製造する方法
CN101437933B (zh) 2005-12-28 2013-11-06 斯克里普斯研究所 作为药物靶标的天然反义和非编码的rna转录物
US7592505B2 (en) 2005-12-30 2009-09-22 Pioneer Hi-Bred International, Inc. UDP-xylose synthases (UXS) polynucleotides, polypeptides, and uses thereof
AU2007204341B2 (en) 2006-01-12 2012-10-04 Basf Plant Science Gmbh Use of stomatin (STM1) polynucleotides for achieving a pathogen resistance in plants
RU2441366C2 (ru) 2006-01-12 2012-02-10 Сайбас Юроп Б.В. Мутанты epsps
EP2422819B1 (en) 2006-01-26 2017-03-01 Ionis Pharmaceuticals, Inc. Compositions and their uses directed to Huntingtin
JP5213723B2 (ja) 2006-01-27 2013-06-19 アイシス ファーマシューティカルズ, インコーポレーテッド マイクロrnaの調節に使用するためのオリゴマー化合物及び組成物
US7569686B1 (en) 2006-01-27 2009-08-04 Isis Pharmaceuticals, Inc. Compounds and methods for synthesis of bicyclic nucleic acid analogs
PL1984381T3 (pl) 2006-01-27 2011-03-31 Isis Pharmaceuticals Inc Zmodyfikowane w pozycji 6 analogi bicykliczne kwasów nukleinowych
US7589257B2 (en) 2006-02-09 2009-09-15 Pioneer Hi-Bred International Inc. Genes for enhancing nitrogen utilization efficiency in crop plants
GB0603160D0 (en) 2006-02-16 2006-03-29 Rothamsted Res Ltd Nucleic acid
EP2221382A3 (en) 2006-03-24 2010-12-01 BASF Plant Science GmbH Proteins associated with abiotic stress response and homologs
EP2439280A1 (en) 2006-03-31 2012-04-11 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
EP2090662A3 (en) 2006-04-05 2012-10-31 Metanomics GmbH Process for the production of a fine chemical
BRPI0710455A2 (pt) 2006-04-19 2011-08-16 Pioneer Hi Bred Int polipeptìdeo isolado, polinucleotìdeo isolado e métodos para aumentar o nìvel de um polipeptìdeo em uma planta, para modular o nìvel de um polipeptìdeo em uma planta e para modificar o crescimento de uma planta
EP2015758B1 (en) 2006-05-05 2014-04-02 Isis Pharmaceuticals, Inc. Compounds and methods for modulating expression apob
US7547684B2 (en) 2006-05-11 2009-06-16 Isis Pharmaceuticals, Inc. 5′-modified bicyclic nucleic acid analogs
US7666854B2 (en) 2006-05-11 2010-02-23 Isis Pharmaceuticals, Inc. Bis-modified bicyclic nucleic acid analogs
CN103103199A (zh) 2006-05-30 2013-05-15 克罗普迪塞恩股份有限公司 具有增强的产量相关性状的伸展蛋白受体样激酶受调节表达的植物和用于产生该植物的方法
ES2402309T3 (es) 2006-05-31 2013-04-30 Metanomics Gmbh Manipulación del metabolismo de nitrógeno usando transportador de amonio o glucosa 6-fosfato deshidrogenasas o farnesil fosfato sintetasas (FPP)
BRPI0712304A2 (pt) 2006-06-08 2012-01-17 Basf Plant Science Gmbh método e processo para melhorar caracterìsticas de crescimento de planta em relação ás plantas de controle correspondentes, planta, parte de planta ou célula de planta, molécula de ácido nucleico isolada, construto de gene, vetor, planta transgênica, e, uso de uma molécula de ácido nucleico ou do construto de gene ou do vetor
KR101105330B1 (ko) 2006-06-15 2012-01-18 재단법인 작물유전체기능연구사업단 Nac 전사인자의 발현 조절로 향상된 수확량 관련 형질을갖는 식물 및 이의 제조 방법
CN105087634A (zh) 2006-06-15 2015-11-25 克罗普迪塞恩股份有限公司 具有增强的产量相关性状的nac转录因子受调节表达的植物和用于产生该植物的方法
CA2893168C (en) * 2006-06-28 2017-11-07 Nucelis Inc. Fatty acid blends and uses therefor
WO2009085033A1 (en) * 2007-12-27 2009-07-09 Cibus Llc Alkylester fatty acid blends and uses therefor
WO2008011473A2 (en) 2006-07-19 2008-01-24 Isis Pharmaceuticals, Inc. Compositions and their uses directed to hbxip
ES2558133T3 (es) 2006-08-02 2016-02-02 Cropdesign N.V. Plantas transformadas con el polipéptido SYT que tienen el rendimiento aumentado en estrés abiótico y procedimiento de producción de las mismas
EP2199396A1 (en) 2006-08-02 2010-06-23 CropDesign N.V. Plants transformed with SYT-polypeptide having increased yield under abiotic stress and a method for making the same
EP2059600B1 (de) 2006-08-30 2014-04-02 BASF Plant Science GmbH Verfahren zur erhöhung der pathogenresistenz in transgenen pflanzen
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
EP2061515A4 (en) 2006-09-14 2013-01-30 Medgenics Medical Israel Ltd LONG-TERM MEDICINAL FORMULATIONS
PL2177605T3 (pl) 2006-10-06 2015-05-29 Basf Plant Science Gmbh Delta-5 desaturazy i sposób wytwarzania wielokrotnie nienasyconych kwasów tłuszczowych w organizmach transgenicznych innych niż człowiek
EP2078087A1 (de) 2006-10-12 2009-07-15 BASF Plant Science GmbH Verfahren zur erhöhung der pathogenresistenz in transgenen pflanzen
US8344205B2 (en) 2006-10-13 2013-01-01 Basf Plant Science Gmbh Plants with increased yield
CA2660439C (en) 2006-10-24 2016-02-16 Basf Plant Science Gmbh Methods for increasing the resistance in plants to biotropic fungi
EP2082049A1 (en) 2006-11-16 2009-07-29 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same using consensus sequences from the yabby protein family
EP2599871A3 (en) 2006-11-24 2013-09-04 CropDesign N.V. Transgenic plants comprising as transgene A class I TCP or clavata 1 (CLV1) or CAH3 polypeptide having increased seed yield and a method for making the same
MX2009005514A (es) 2006-12-15 2009-06-04 Cropdesign Nv Plantas que presentan un incremento de sus rasgos relacionados con el rendimiento y un metodo para producirlas.
EP2069505A2 (en) 2006-12-21 2009-06-17 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for method for making the same
EP1935428A1 (en) * 2006-12-22 2008-06-25 Antisense Pharma GmbH Oligonucleotide-polymer conjugates
CA2674243C (en) 2006-12-28 2017-05-30 Pioneer Hi-Bred International, Inc. Genetic markers for orobanche resistance in sunflower
ES2476842T3 (es) * 2007-01-10 2014-07-15 Purdue Research Foundation Inhibidores polipept�dicos de HSP27 quinasa y usos de los mismos
EP2202314B1 (en) 2007-01-15 2014-03-12 BASF Plant Science GmbH Use of subtilisin (RNR9) polynucleotides for achieving a pathogen resistance in plants
CA2674740A1 (en) 2007-01-30 2008-08-07 Cropdesign N.V. Plants having enhanced yield-related traits and a method for making the same
AR065121A1 (es) 2007-01-31 2009-05-20 Basf Plant Science Gmbh Plantas con rasgos aumentados relacionados con el rendimiento y/o resistencia incrementada al estres abiotico y un metodo para desarrollar las mismas
KR101488800B1 (ko) 2007-02-09 2015-02-04 노오쓰웨스턴 유니버시티 세포내 타겟 검출용 입자
EP2118286B1 (en) 2007-02-28 2016-04-13 Cropdesign N.V. Plants having enhanced yield-related traits and a method for making the same
US8153863B2 (en) 2007-03-23 2012-04-10 New York University Transgenic plants expressing GLK1 and CCA1 having increased nitrogen assimilation capacity
EP2561750A1 (en) 2007-04-04 2013-02-27 BASF Plant Science GmbH AHAS mutants
US9156865B2 (en) 2007-04-23 2015-10-13 Deliversir Ltd System for delivering therapeutic agents into living cells and cells nuclei
US9556210B2 (en) 2007-04-23 2017-01-31 Sabag-Rfa Ltd. System for delivering therapeutic agents into living cells and cells nuclei
ES2516827T3 (es) * 2007-04-23 2014-10-31 Deliversir Ltd Un sistema para entregar agentes terapéuticos a células vivas y núcleos de células
EP2316956B1 (en) 2007-05-03 2015-04-22 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
WO2008142034A2 (en) 2007-05-22 2008-11-27 Basf Plant Science Gmbh Plants with increased tolerance and/or resistance to environmental stress and increased biomass production
AU2008252998A1 (en) 2007-05-22 2008-11-27 Basf Plant Science Gmbh Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production-KO
WO2008142163A2 (en) 2007-05-23 2008-11-27 Cropdesign N.V. Plants having enhanced yield-related traits and a method for making the same
WO2008145629A2 (en) 2007-05-25 2008-12-04 Cropdesign N.V. Yield enhancement in plants by modulation of maize alfins
DK2160464T3 (da) 2007-05-30 2014-08-04 Univ Northwestern Nukleinsyrefunktionaliserede nanopartikler til terapeutiske anvendelser
US8278425B2 (en) 2007-05-30 2012-10-02 Isis Pharmaceuticals, Inc. N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
US8278426B2 (en) 2007-06-08 2012-10-02 Isis Pharmaceuticals, Inc. Carbocyclic bicyclic nucleic acid analogs
WO2009003977A2 (en) 2007-06-29 2009-01-08 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
WO2009006478A2 (en) 2007-07-05 2009-01-08 Isis Pharmaceuticals, Inc. 6-disubstituted bicyclic nucleic acid analogs
AR067633A1 (es) 2007-07-20 2009-10-21 Basf Plant Science Gmbh Plantas que tienen rasgos aumentados relacionados con el rendimiento y un metodo para producirlas
AR067748A1 (es) 2007-07-31 2009-10-21 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas
KR101269931B1 (ko) 2007-07-31 2013-05-31 재단법인 작물유전체기능연구사업단 향상된 수확량 관련 형질을 갖는 식물 및 이의 제조 방법
JP5703466B2 (ja) 2007-08-07 2015-04-22 パーデュー・リサーチ・ファウンデーションPurdue Research Foundation キナーゼ阻害薬およびその使用
CN101821277B (zh) 2007-08-15 2014-05-07 Isis制药公司 四氢吡喃核酸类似物
AR069824A1 (es) 2007-09-14 2010-02-24 Basf Plant Science Gmbh Plantas con rasgos aumentados relacionados con el rendimiento y un metodo para producirlas
AU2008300579B2 (en) 2007-09-18 2014-11-13 Basf Plant Science Gmbh Plants with increased yield
WO2009037329A2 (en) 2007-09-21 2009-03-26 Basf Plant Science Gmbh Plants with increased yield
UA103176C2 (ru) 2007-09-21 2013-09-25 Басф Плант Саенс Гмбх Растение с повышенными показателями урожайности и способ его получения
US7951785B2 (en) 2007-09-21 2011-05-31 California Institute Of Technology NFIA in glial fate determination, glioma therapy and astrocytoma treatment
BR122018070230B1 (pt) * 2007-10-05 2023-01-10 Cibus Europe B.V. Método para produção de planta resistente à herbicida
US20100280098A1 (en) * 2007-10-05 2010-11-04 Juliano Rudolph L Receptor targeted oligonucleotides
US20110071047A1 (en) * 2007-10-27 2011-03-24 O.D. 260 Inc. Promoter detection and analysis
US20090111099A1 (en) * 2007-10-27 2009-04-30 Yongsheng Ma Promoter Detection and Analysis
MX2010004305A (es) 2007-10-29 2010-04-30 Basf Plant Science Gmbh Plantas que tienen rasgos relacionados con el rendimiento aumentado y un metodo para producirlas.
WO2009064771A2 (en) 2007-11-12 2009-05-22 North Carolina State University Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
WO2009064920A2 (en) 2007-11-13 2009-05-22 Isis Pharmaceuticals, Inc. Compounds and methods for modulating protein expression
EP2222851B1 (en) 2007-11-20 2017-06-28 Ionis Pharmaceuticals, Inc. Modulation of cd40 expression
WO2009067580A2 (en) 2007-11-20 2009-05-28 Pioneer Hi-Bred International, Inc. Maize ethylene signaling genes and modulation of same for improved stress tolerance in plants
WO2009067647A1 (en) * 2007-11-21 2009-05-28 Isis Pharmaceuticals, Inc. Carbocyclic alpha-l-bicyclic nucleic acid analogs
AU2008327899B2 (en) 2007-11-22 2014-04-03 Cropdesign N.V. Plants having increased yield-related traits and a method for making the same
MX2010005697A (es) 2007-11-26 2010-06-11 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas.
AU2008337398B2 (en) 2007-12-19 2014-04-03 Basf Plant Science Gmbh Plants with increased yield and/or increased tolerance to environmental stress (IY-BM)
WO2009080802A2 (en) 2007-12-20 2009-07-02 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
WO2009080743A2 (en) 2007-12-21 2009-07-02 Basf Plant Science Gmbh Plants with increased yield (ko nue)
WO2009092772A2 (en) 2008-01-25 2009-07-30 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
CA2713065A1 (en) 2008-01-31 2009-08-06 National Institute For Biological Sciences Plants having altered growth and/or development and a method for making the same
WO2009100320A2 (en) 2008-02-07 2009-08-13 Isis Pharmaceuticals, Inc. Bicyclic cyclohexitol nucleic acid analogs
AU2009218478A1 (en) 2008-02-27 2009-09-03 Basf Plant Science Gmbh Plants with increased yield
WO2009117589A1 (en) 2008-03-21 2009-09-24 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising tricyclic nucleosides and methods for their use
EP2285819B1 (en) 2008-04-04 2013-10-16 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising neutrally linked terminal bicyclic nucleosides
CN102066568A (zh) 2008-04-16 2011-05-18 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
CA2722806A1 (en) 2008-05-05 2009-11-12 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
EP2279255A4 (en) 2008-05-23 2012-03-07 Coh Inc PREPARATION OF SQUALES BY YEAST
CN102066569A (zh) 2008-06-20 2011-05-18 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和产生所述植物的方法
DE112009001405T5 (de) 2008-06-26 2011-07-28 BASF Plant Science GmbH, 67063 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zu deren Herstellung
DE112009001560T5 (de) 2008-07-04 2012-01-26 Basf Plant Science Gmbh Planzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben
CN102099480A (zh) 2008-07-17 2011-06-15 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
CA2731038A1 (en) 2008-07-31 2010-02-04 Basf Plant Science Gmbh Plants having modified growth characteristics and a method for making the same
WO2010017248A2 (en) 2008-08-04 2010-02-11 University Of Miami Sting (stimulator of interferon genes), a regulator of innate immune responses
WO2010020654A2 (en) 2008-08-19 2010-02-25 Basf Plant Science Gmbh Plants with increased yield by increasing or generating one or more activities in a plant or a part thereof
MX2011001475A (es) 2008-08-20 2011-03-29 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas.
KR101877698B1 (ko) 2008-08-25 2018-07-12 엑스칼리아드 파마슈티컬즈, 인코포레이티드 결합 조직 성장 인자에 대한 안티센스 올리고뉴클레오타이드 및 그의 용도
CA2737303C (en) 2008-09-11 2019-06-11 Keygene N.V. Method for diagnostic marker development
AU2009295982A1 (en) 2008-09-23 2010-04-01 Basf Plant Science Gmbh Plants with increased yield (LT)
WO2010036698A1 (en) 2008-09-24 2010-04-01 Isis Pharmaceuticals, Inc. Substituted alpha-l-bicyclic nucleosides
AU2009295991A1 (en) 2008-09-24 2010-04-01 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
WO2010036696A1 (en) 2008-09-24 2010-04-01 Isis Pharmaceuticals, Inc. Cyclohexenyl nucleic acid analogs
AP2011005671A0 (en) 2008-09-26 2011-04-30 Basf Agrochemical Products Bv Herbicide-resistant AHAS-mutants and methods of use.
CA2966011C (en) 2008-10-15 2021-10-19 Ionis Pharmaceuticals, Inc. Modulation of factor 11 expression
AU2009322865B2 (en) * 2008-10-20 2013-07-18 Moerae Matrix, Inc. Polypeptide for treating or preventing adhesions
AR075466A1 (es) 2008-10-22 2011-04-06 Basf Se Uso de herbicidas tipo auxina en plantas cultivadas
AR075465A1 (es) 2008-10-22 2011-04-06 Basf Se Uso de herbicidas de sulfonilurea en plantas cultivadas
AU2009306575B2 (en) 2008-10-23 2016-04-14 Basf Plant Science Gmbh Plants with increased yield (NUE)
AR073969A1 (es) 2008-10-23 2010-12-15 Basf Plant Science Gmbh Un metodo para producir una celula transgenca con mayor contenido de acido gamma aminobutirico ( gaba)
AU2009308217B2 (en) 2008-10-24 2016-01-21 Ionis Pharmaceuticals, Inc. 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
EP2358398A2 (en) 2008-10-24 2011-08-24 Isis Pharmaceuticals, Inc. Oligomeric compounds and methods
EP2184351A1 (en) 2008-10-30 2010-05-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Polynucleotides encoding caryophyllene synthase and uses thereof
CA2741006A1 (en) 2008-10-30 2010-05-20 Pioneer Hi-Bred International, Inc. Manipulation of glutamine synthetases (gs) to improve nitrogen use efficiency and grain yield in higher plants
EP2358880A1 (en) 2008-11-12 2011-08-24 BASF Plant Science Company GmbH Plants having enhanced abiotic stress tolerance and/or enhanced yield-related traits and a method for making the same
MX307031B (es) 2008-11-14 2012-12-13 Fujian Fuda Biotech Co Ltd Una fitasa escherichia coli no-k12 termotolerante y su produccion.
CA2744207C (en) 2008-11-24 2019-05-28 Northwestern University Polyvalent rna-nanoparticle compositions
CN102300991A (zh) 2008-12-03 2011-12-28 巴斯夫植物科学有限公司 具有增强的非生物胁迫耐受性和/或增强的产量相关性状的植物及其制备方法
EP2370579B1 (en) 2008-12-04 2017-03-29 CuRNA, Inc. Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
WO2010065867A1 (en) 2008-12-04 2010-06-10 Pioneer Hi-Bred International, Inc. Methods and compositions for enhanced yield by targeted expression of knotted1
WO2010065662A2 (en) 2008-12-04 2010-06-10 Curna, Inc. Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
WO2010065787A2 (en) 2008-12-04 2010-06-10 Curna, Inc. Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
AU2009324661A1 (en) 2008-12-10 2011-07-07 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
AU2009326129B2 (en) 2008-12-12 2016-05-12 Basf Plant Science Gmbh Desaturases and process for the production of polyunsaturated fatty acids in transgenic organisms
WO2010080554A1 (en) 2008-12-17 2010-07-15 Avi Biopharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
EP2379582A1 (en) 2008-12-17 2011-10-26 BASF Plant Science GmbH Plants having enhanced yield-related traits and/or abiotic stress tolerance and a method for making the same
EP2204086A1 (en) 2009-01-02 2010-07-07 Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK) Six row-type barley
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
AU2010204723A1 (en) 2009-01-14 2011-08-18 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases
EP2391719A1 (en) 2009-01-28 2011-12-07 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
US8536320B2 (en) 2009-02-06 2013-09-17 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
EP2393825A2 (en) 2009-02-06 2011-12-14 Isis Pharmaceuticals, Inc. Oligomeric compounds and methods
CN102387817B (zh) 2009-02-12 2018-01-30 库尔纳公司 通过抑制针对脑衍生神经营养因子(bdnf)的天然反义转录物来治疗bdnf相关的疾病
JP6066035B2 (ja) 2009-02-12 2017-01-25 クルナ・インコーポレーテッド グリア細胞由来神経栄養因子(gdnf)関連疾病の、gdnfに対する天然アンチセンス転写物の抑制による治療
DE112010000887T5 (de) 2009-02-25 2012-09-27 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung
WO2010101818A1 (en) 2009-03-02 2010-09-10 Pioneer Hi-Bred International, Inc. Nac transcriptional activators involved in abiotic stress tolerance
EP2963116B1 (en) 2009-03-04 2020-11-11 CuRNA, Inc. Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt 1
EP2408919B1 (en) 2009-03-16 2017-10-18 CuRNA, Inc. Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2
CN102549159B (zh) 2009-03-17 2016-08-10 库尔纳公司 通过抑制针对δ样1同源物(DLK1)的天然反义转录物来治疗DLK1相关的疾病
EA201171245A1 (ru) 2009-04-14 2012-05-30 Пайонир Хай-Бред Интернешнл, Инк. Модуляция acc-синтазы, улучшающая урожайность растений при условиях низкого содержания азота
AU2010241034A1 (en) 2009-04-21 2011-11-24 Basf Plant Science Company Gmbh RNA-mediated induction of gene expression in plants
AU2010241030A1 (en) 2009-04-21 2011-11-10 Basf Plant Science Company Gmbh RNA-mediated induction of gene expression in plants
EP3248618A1 (en) 2009-04-22 2017-11-29 Massachusetts Institute Of Technology Innate immune suppression enables repeated delivery of long rna molecules
BRPI1014386A2 (pt) 2009-04-29 2015-08-25 Basf Plant Science Co Gmbh Métodos para intensificar traços relacionados com o rendimento em plantas com relação às plantas de controle, construção, uso de uma construção, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica, partes colhíveis de uma planta, produtos, uso de um ácido nucleico, molécula de ácido nucleico isolada, e, polipeptídeo.
CA2760429A1 (en) 2009-04-29 2010-11-04 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
ES2661787T3 (es) 2009-05-01 2018-04-04 Curna, Inc. Tratamiento de enfermedades relacionadas con hemoglobina (hbf/hbg) por inhibición de transcrito antisentido natural para hbf/hbg
MX2011011678A (es) 2009-05-04 2011-12-06 Pioneer Hi Bred Int Mejora de la produccion en plantas mediante la modulacion del factor de transcripcion ap2.
CA2761152A1 (en) 2009-05-06 2010-11-11 Opko Curna, Llc Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
US20120096593A1 (en) 2009-05-06 2012-04-19 Yves Hatzfeld Plants Having Enhanced Yield-Related Traits And/Or Enhanced Abiotic Stress Tolerance And A Method For Making The Same
US20120046236A1 (en) 2009-05-06 2012-02-23 Opko Curna Llc Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
DK2432881T3 (en) 2009-05-18 2018-02-26 Curna Inc TREATMENT OF REPROGRAMMING FACTOR-RELATED DISEASES BY INHIBITING NATURAL ANTISENSE TRANSCRIPTS TO A REPROGRAMMING FACTOR
WO2010135695A2 (en) 2009-05-22 2010-11-25 Curna, Inc. TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3
KR20120024819A (ko) 2009-05-28 2012-03-14 오피케이오 큐알엔에이, 엘엘씨 항바이러스 유전자에 대한 천연 안티센스 전사체의 억제에 의한 트리스테트라프롤린 관련된 질환의 치료
KR101801404B1 (ko) 2009-06-16 2017-12-20 큐알엔에이, 인크. 콜라겐 유전자에 대한 천연 안티센스 전사체의 억제에 의한 콜라겐 유전자 관련된 질환의 치료
ES2629339T3 (es) 2009-06-16 2017-08-08 Curna, Inc. Tratamiento de enfermedades relacionadas con la paraoxonasa 1 (pon1) por inhibición de transcrito antisentido natural a pon1
AU2010272805A1 (en) 2009-06-19 2012-01-19 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
ES2618894T3 (es) 2009-06-24 2017-06-22 Curna, Inc. Tratamiento de enfermedades relacionadas con el receptor del factor de necrosis tumoral 2 (tnfr2) por inhibición del transcrito natural antisentido para tnfr2
JP5907866B2 (ja) 2009-06-26 2016-04-26 クルナ・インコーポレーテッド ダウン症候群遺伝子に対する天然アンチセンス転写物の抑制によるダウン症候群遺伝子関連疾患の治療
US20120174261A1 (en) 2009-06-30 2012-07-05 E. I. Du Pont De Nemours And Company Plant seeds with alterred storage compound levels, related constructs and methods involving genes encoding cytosolic pyrophosphatase
ES2385451T3 (es) 2009-07-10 2012-07-25 Freie Universität Berlin Rock2 y Rock3, dos nuevas variantes de ganancia de función de los receptores de citoquinina AHK2 y AHK3
EP2275564A1 (en) 2009-07-17 2011-01-19 Freie Universität Berlin Means and method for the production of transgenic plants that are resistant to clubroot
US20120117867A1 (en) 2009-07-23 2012-05-17 Basf Plant Science Company Gmbh Plants with Increased Yield
US9175301B2 (en) 2009-07-24 2015-11-03 Pioneer Hi Bred International Inc Use of dimerization domain component stacks to modulate plant architecture
US9890195B2 (en) * 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
WO2011017492A2 (en) 2009-08-05 2011-02-10 Pioneer Hi-Bred International, Inc. Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
ES2585360T3 (es) 2009-08-05 2016-10-05 Curna, Inc. Tratamiento de enfermedades relacionadas con un gen de la insulina (INS) por inhibición de la transcripción antisentido natural en un gen de la insulina (INS)
EP2462153B1 (en) 2009-08-06 2015-07-29 Isis Pharmaceuticals, Inc. Bicyclic cyclohexose nucleic acid analogs
GB0914012D0 (en) 2009-08-11 2009-09-16 Plant Bioscience Ltd Stress tolerant plants
EA201200284A1 (ru) 2009-08-19 2013-03-29 Басф Плант Сайенс Компани Гмбх Растения, имеющие улучшенные характеристики, связанные с урожаем, и способ создания таких
EP2467472A2 (en) 2009-08-20 2012-06-27 Pioneer Hi-Bred International Inc. Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake
EP2470657B1 (en) 2009-08-25 2019-10-23 CuRNA, Inc. Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
CN109468339B (zh) 2009-08-31 2022-11-04 巴斯夫植物科学有限公司 用于增强植物中组成型基因表达的调节性核酸分子
BR122021003079B1 (pt) 2009-08-31 2022-05-10 Basf Plant Science Company Gmbh Método de produção de um promotor vegetal, método de produção de uma planta, construção, vetor, microrganismo transgênico e usos do neena e da construção recombinante ou vetor recombinante
RU2012112348A (ru) 2009-08-31 2013-10-10 Басф Плант Сайенс Компани Гмбх Регуляторные молекулы нуклеиновых кислот для усиления семя-специфичной генной экспрессии в растениях, стимулирующие усиленный синтез полиненасыщенных жирных кислот
JP5887270B2 (ja) 2009-09-02 2016-03-16 ジェネンテック, インコーポレイテッド 突然変異体smoothenedおよびその使用方法
KR101754083B1 (ko) 2009-09-25 2017-07-05 바스프 플랜트 사이언스 컴퍼니 게엠베하 향상된 수확량 관련 형질을 갖는 식물 및 이의 제조 방법
MX2012003451A (es) 2009-09-25 2012-05-22 Basf Plant Science Co Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para prepararlas.
MX2012003972A (es) 2009-10-02 2012-05-08 Pionner Hi Bred International Inc Regulacion a la baja de acc sintasa para mejorar el rendimiento de las plantas.
JP5819308B2 (ja) 2009-10-22 2015-11-24 ジェネンテック, インコーポレイテッド マクロファージ刺激タンパク質のヘプシン活性化を調節するための方法及び組成物
MX2012004659A (es) 2009-10-22 2012-07-30 Basf Plant Science Co Gmbh Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas.
AR078829A1 (es) 2009-10-30 2011-12-07 Du Pont Plantas y semillas con niveles alterados de compuesto de almacenamiento, construcciones relacionadas y metodos relacionados con genes que codifican proteinas similares a las aldolasas bacterianas de la clase ii del acido 2,4- dihidroxi-hept-2-eno-1,7-dioico
US9376690B2 (en) 2009-10-30 2016-06-28 Northwestern University Templated nanoconjugates
DE112010004383T5 (de) 2009-11-13 2012-08-23 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung
CA2779830C (en) 2009-11-13 2020-07-21 Avi Biopharma, Inc. Antisense antiviral compound and method for treating influenza viral infection
AU2010320547B2 (en) 2009-11-17 2016-06-09 Basf Plant Science Company Gmbh Plants with increased yield
ES2625154T3 (es) * 2009-11-23 2017-07-18 Nucelis Llc Métodos y composiciones para producir escualeno empleando levaduras
NZ599707A (en) 2009-11-30 2014-07-25 Genentech Inc Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 )
WO2011084455A2 (en) 2009-12-16 2011-07-14 Opko Curna, Llc. Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1
JP5934106B2 (ja) 2009-12-23 2016-06-15 カッパーアールエヌエー,インコーポレイテッド 肝細胞増殖因子(hgf)に対する天然アンチセンス転写物の阻害によるhgf関連性疾患の治療
US9068183B2 (en) 2009-12-23 2015-06-30 Curna, Inc. Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2
AU2010343143A1 (en) 2009-12-28 2012-06-28 Pioneer Hi-Bred International, Inc. Sorghum fertility restorer genotypes and methods of marker-assisted selection
KR101853508B1 (ko) 2009-12-29 2018-06-20 큐알엔에이, 인크. 종양 단백질 63 (p63)에 대한 천연 안티센스 전사체의 억제에 의한 p63에 관련된 질환의 치료
EP2519633B1 (en) 2009-12-29 2017-10-25 CuRNA, Inc. Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
BR112012016290A2 (pt) 2009-12-31 2015-09-01 Pioneer Hi Bred Int Ácido nucléico isolado ou recombinante, cassete de expressão, célula hospedeira não humana, planta e semente transgênica, variante de polipeptídeo oxox isolado ou recombinante, método de modulação do nível de proteina oxalato oxidase (oxox) em uma planta ou célula vegetal, método para aumentar a resistência de uma planta a um patógeno, planta resistente a patógeno, método para identificar variantes oxox com atividade de oxox mantida ou aumentada, método para gerar uma planta que tem resistência aumentada a uma patógeno
US8946181B2 (en) 2010-01-04 2015-02-03 Curna, Inc. Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8
US20110167517A1 (en) 2010-01-06 2011-07-07 Pioneer Hi-Bred International, Inc. Identification of diurnal rhythms in photosynthetic and non-photsynthetic tissues from zea mays and use in improving crop plants
EP2521785B1 (en) 2010-01-06 2022-03-09 CuRNA, Inc. Inhibition of natural antisense transcript to a pancreatic developmental gene for use in a treatment of pancreatic developmental gene related diseases
WO2011085347A2 (en) 2010-01-11 2011-07-14 Opko Curna, Llc Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg
WO2011085102A1 (en) 2010-01-11 2011-07-14 Isis Pharmaceuticals, Inc. Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom
WO2011091244A1 (en) 2010-01-21 2011-07-28 NellOne Therapeutics, Inc. Methods to treat or prevent a skin condition using a nell1 peptide
RU2611192C2 (ru) 2010-01-25 2017-02-21 Курна, Инк. ЛЕЧЕНИЕ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С РНКазой Н1, ПУТЕМ ИНГИБИРОВАНИЯ ПРИРОДНОГО АНТИСМЫСЛОВОГО ТРАНСКРИПТА К РНКазе Н1
EP2529028A1 (en) 2010-01-26 2012-12-05 Pioneer Hi-Bred International, Inc. Polynucleotide and polypeptide sequences associated with herbicide tolerance
JP5976548B2 (ja) 2010-02-22 2016-08-23 カッパーアールエヌエー,インコーポレイテッド Pycr1に対する天然アンチセンス転写物の阻害によるピロリン−5−カルボン酸レダクターゼ1(pycr1)関連疾患の治療
WO2011105902A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 8-beta (c8-beta) and uses thereof
WO2011105900A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 8-alpha (c8-alpha) and uses thereof
WO2011105901A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 9 (c9) and uses thereof
AU2011221226A1 (en) 2010-02-23 2012-08-16 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2011104128A2 (en) 2010-02-24 2011-09-01 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
CN102939385A (zh) 2010-02-24 2013-02-20 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
EP2361985A1 (en) 2010-02-26 2011-08-31 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
EP2361927A1 (en) 2010-02-26 2011-08-31 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
WO2011109618A2 (en) 2010-03-03 2011-09-09 E. I. Du Pont De Nemours And Company Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding oxidoreductase motif polypeptides
GB201003702D0 (en) 2010-03-05 2010-04-21 Univ Warwick Molecular engineering of a floral inducer for crop improvement
EP2545173A2 (en) 2010-03-12 2013-01-16 Sarepta Therapeutics, Inc. Antisense modulation of nuclear hormone receptors
US8906875B2 (en) 2010-03-12 2014-12-09 The Brigham And Women's Hospital, Inc. Methods of treating vascular inflammatory disorders
US9193752B2 (en) 2010-03-17 2015-11-24 Isis Pharmaceuticals, Inc. 5′-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
WO2011114279A1 (en) 2010-03-18 2011-09-22 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
US20130036516A1 (en) 2010-03-18 2013-02-07 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
US20130019347A1 (en) 2010-03-19 2013-01-17 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
CN102971427A (zh) 2010-03-19 2013-03-13 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
EP2371845A1 (en) 2010-03-22 2011-10-05 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
TWI644675B (zh) 2010-04-09 2018-12-21 可娜公司 藉由抑制纖維母細胞生長因子21(fgf21)之天然反義轉錄物以治療fgf21相關疾病
EP2385129A1 (en) 2010-05-03 2011-11-09 BASF Plant Science Company GmbH Enhanced methods for gene regulation in plants
US8980253B2 (en) 2010-04-26 2015-03-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
CA2797362C (en) 2010-04-27 2020-12-08 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
US9127033B2 (en) 2010-04-28 2015-09-08 Isis Pharmaceuticals, Inc. 5′ modified nucleosides and oligomeric compounds prepared therefrom
JP6005628B2 (ja) 2010-04-28 2016-10-12 アイオーニス ファーマシューティカルズ, インコーポレーテッドIonis Pharmaceuticals,Inc. 修飾ヌクレオシド、その類似体、およびこれらから調製されるオリゴマー化合物
EP2563911B1 (en) 2010-04-28 2021-07-21 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
BR112012027547B1 (pt) 2010-04-29 2022-06-14 Ionis Pharmaceuticals, Inc Oligonucleotídeo modificado de fita simples, composição, e seus usos para tratar amiloidose transtirretina, reduzir os seus sintomas e para reduzir a expressão de mrna ou de proteína de transtirretina
EP2563912B1 (en) 2010-04-29 2018-09-05 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
CA2797393C (en) 2010-04-29 2020-03-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
JP5976638B2 (ja) 2010-05-03 2016-08-23 エータイアー ファーマ, インコーポレイテッド アルギニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
RU2018110641A (ru) 2010-05-03 2019-02-27 Курна, Инк. Лечение заболеваний, связанных с сиртуином (sirt), путем ингибирования природного антисмыслового транскрипта к сиртуину (sirt)
CN102958941A (zh) 2010-05-03 2013-03-06 霍夫曼-拉罗奇有限公司 用于肿瘤诊断和治疗的组合物和方法
JP6008841B2 (ja) 2010-05-03 2016-10-19 エータイアー ファーマ, インコーポレイテッド メチオニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
US9034321B2 (en) 2010-05-03 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
CA2798139C (en) 2010-05-04 2019-09-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
BR112012028132A2 (pt) 2010-05-04 2015-09-15 Basf Se plantas que tem tolerância aumentada a herbicidas
MX2012012672A (es) 2010-05-06 2012-12-17 Du Pont Gen y proteina acc sintasa 3 de maiz y sus usos.
GB201007834D0 (en) 2010-05-11 2010-06-23 Vib Vzw Growth promoting fusion proteins
JP5866106B2 (ja) 2010-05-12 2016-02-17 コロンビア ユニヴァーシティ インスリンを産生し分泌する腸内分泌細胞の製造方法
US9238042B2 (en) 2010-05-13 2016-01-19 Sarepta Therapeutics, Inc. Antisense modulation of interleukins 17 and 23 signaling
TWI586356B (zh) 2010-05-14 2017-06-11 可娜公司 藉由抑制par4天然反股轉錄本治療par4相關疾病
CN103200953B (zh) 2010-05-14 2017-02-15 Atyr 医药公司 与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
WO2011146410A2 (en) 2010-05-17 2011-11-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
RU2585229C2 (ru) 2010-05-26 2016-05-27 Курна, Инк. Лечение заболеваний, связанных с атональным гомологом 1 (атон1), путем ингибирования природного антисмыслового транскрипта гена атон1
EP2575856B1 (en) 2010-05-27 2017-08-16 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
US8957200B2 (en) 2010-06-07 2015-02-17 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
WO2011156202A1 (en) 2010-06-08 2011-12-15 Isis Pharmaceuticals, Inc. Substituted 2 '-amino and 2 '-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
EP2582396A4 (en) 2010-06-15 2014-01-01 Medgenics Medical Israel Ltd REMEDY FORMULATIONS WITH LONG-TERM EFFECT
WO2011161617A1 (en) 2010-06-24 2011-12-29 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
AU2011268562A1 (en) 2010-06-25 2013-01-10 Basf Plant Science Company Gmbh Plants with enhanced yield-related traits and producing method thereof
BR112012033668A2 (pt) 2010-07-01 2017-06-13 Du Pont planta e semente transgênica, método para a produção de um planta transgênica, produto e/ou subproduto obtido a partir da semente transgênica, polinucleotídeo isolado e planta ou semente compreendendo uma cosntrução de dna recombinante
CA2804487A1 (en) 2010-07-08 2012-01-12 University Of Copenhagen Glucosinolate transporter protein and uses thereof
CN103118695B (zh) 2010-07-12 2016-08-03 Atyr医药公司 与甘氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
RU2611190C2 (ru) 2010-07-14 2017-02-21 Курна, Инк. Лечение заболеваний, связанных с геном dlg, путем ингибирования природного антисмыслового транскрипта гена dlg
EA201390111A1 (ru) 2010-07-16 2013-06-28 Басф Плант Сайенс Компани Гмбх Растения с улучшенными характеристиками урожайности и способ их получения
US20120122223A1 (en) 2010-08-03 2012-05-17 Cibus Us Llc Mutated protoporphyrinogen ix oxidase (ppx) genes
UA112969C2 (uk) 2010-08-03 2016-11-25 Сібас Юс Ллс Рослина, стійка до одного або більше ррх-інгібуючих гербіцидів, яка містить мутантний ген протопорфіриноген ix оксидази (ррх)
EP2603591A1 (en) 2010-08-13 2013-06-19 Pioneer Hi-Bred International Inc. Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (hppd) activity
US20140026257A1 (en) 2010-08-24 2014-01-23 Basf Plant Science Company Gmbh Plants Having Enhanced Yield-Related Traits and Method for Making the Same
US9029506B2 (en) 2010-08-25 2015-05-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases
WO2012028673A1 (en) 2010-09-02 2012-03-08 Ludwig-Maximilians-Universitaet Muenchen Spontaneous organogenesis in plants
EP2426204A1 (en) 2010-09-02 2012-03-07 Ludwig-Maximilians-Universität München Spontaneous nodule organogenesis in plants
DK2625197T3 (en) 2010-10-05 2016-10-03 Genentech Inc Smoothened MUTANT AND METHODS OF USING THE SAME
CN103210086B (zh) 2010-10-06 2017-06-09 库尔纳公司 通过抑制唾液酸酶4(neu4)的天然反义转录物而治疗neu4相关疾病
EP2625292B1 (en) 2010-10-07 2018-12-05 The General Hospital Corporation Biomarkers of cancer
US9222088B2 (en) 2010-10-22 2015-12-29 Curna, Inc. Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
ES2677070T3 (es) 2010-10-27 2018-07-27 Curna, Inc. Tratamiento de enfermedades relacionadas con el regulador del desarrollo 1 asociado a interferón (ifrd1) mediante inhibición del transcrito antisentido natural al gen ifrd1
AU2011327749A1 (en) 2010-11-10 2013-05-30 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
AU2011325956B2 (en) 2010-11-12 2016-07-14 The General Hospital Corporation Polycomb-associated non-coding RNAs
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
CA3077910A1 (en) 2010-11-17 2012-05-24 Ionis Pharmaceuticals, Inc. Modulation of alpha synuclein expression
ES2657590T3 (es) 2010-11-23 2018-03-06 Curna, Inc. Tratamiento de enfermedades relacionadas con nanog mediante inhibición del transcrito antisentido natural a nanog
BR112013014037A2 (pt) 2010-12-06 2017-06-06 Basf Plant Science Co Gmbh método para a produção de uma ou mais moléculas de ácido nucleico, molécula de ácido nucleico reguladora, construto de expressão, vetor, micro-organismo, célula de planta ou célula animal e planta
MX347362B (es) 2010-12-16 2017-04-10 Basf Agro Bv Plantas que tienen mayor tolerancia a herbicidas.
US9702013B2 (en) 2010-12-22 2017-07-11 Pioneer Hi-Bred International, Inc. QTLs associated with and methods for identifying whole plant field resistance to Sclerotinia
WO2012097261A2 (en) 2011-01-14 2012-07-19 The General Hospital Corporation Methods targeting mir-128 for regulating cholesterol/lipid metabolism
MX2013008086A (es) 2011-01-20 2013-10-03 Basf Plant Science Co Gmbh Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas.
US9688719B2 (en) 2011-01-27 2017-06-27 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
US9243034B2 (en) 2011-01-27 2016-01-26 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
CA2826284C (en) 2011-02-01 2021-06-08 Colorado Wheat Research Foundation, Inc. Acetyl co-enzyme a carboxylase herbicide resistant plants
WO2012106509A1 (en) 2011-02-02 2012-08-09 The Trustees Of Princeton University Sirtuin modulators as virus production modulators
SI2670411T1 (sl) 2011-02-02 2019-06-28 Excaliard Pharmaceuticals, Inc. Protismiselne spojine, ki so usmerjene na rastni faktor veznega tkiva (CTGF), za uporabo v postopku zdravljenja keloidov ali hipertrofnih brazgotin
US9273336B2 (en) 2011-02-21 2016-03-01 E. I. Du Pont De Nemours And Company Recombinant host cells having an increase in buoyant density
AR085394A1 (es) 2011-02-25 2013-09-25 Univ Nac De La Plata Unlp Proteasa de plantas
US20140033368A1 (en) 2011-02-28 2014-01-30 Valerie Frankard Plants Having Enhanced Yield-Related Traits and Producing Methods Thereof
EA201391243A1 (ru) 2011-02-28 2014-07-30 Басф Плант Сайенс Компани Гмбх Растения, обладающие повышенными связанными с урожайностью свойствами, и способ их получения
MX2013009997A (es) 2011-03-01 2014-07-09 Basf Plant Science Co Gmbh Plantas que tienen rasgos relacionados con rendimiento mejorado y metodos para producir los mismos.
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
CA3042808A1 (en) 2011-04-12 2012-10-18 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
WO2012148835A1 (en) 2011-04-29 2012-11-01 Pioneer Hi-Bred International, Inc. Down-regulation of a homeodomain-leucine zipper i-class homeobox gene for improved plant performance
WO2012156760A1 (en) 2011-05-19 2012-11-22 Consejo Superior De Investigaciones Cientificas Process for modifying the architecture and improving the yield of crop plants
WO2012170347A1 (en) 2011-06-09 2012-12-13 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
JP6188686B2 (ja) 2011-06-09 2017-08-30 カッパーアールエヌエー,インコーポレイテッド フラタキシン(fxn)への天然アンチセンス転写物の阻害によるfxn関連疾患の治療
EP2721160A2 (en) 2011-06-14 2014-04-23 Synthon Biopharmaceuticals B.V. Compositions and methods for making and biocontaining auxotrophic transgenic plants
AR087167A1 (es) 2011-07-12 2014-02-26 Two Blades Foundation Genes de resistencia al tizon tardio
WO2013012643A1 (en) 2011-07-15 2013-01-24 Syngenta Participations Ag Polynucleotides encoding trehalose-6-phosphate phosphatase and methods of use thereof
US9556449B2 (en) 2011-07-15 2017-01-31 Syngenta Participations Ag Methods of increasing yield and stress tolerance in a plant by decreasing the activity of a trehalose-6-phosphate phosphatase
CN103732747A (zh) 2011-08-01 2014-04-16 巴斯夫植物科学有限公司 鉴定和分离导致转录增强的终止子序列的方法
CA2848753C (en) 2011-09-14 2022-07-26 Rana Therapeutics, Inc. Multimeric oligonucleotide compounds
US9889209B2 (en) 2011-09-14 2018-02-13 Northwestern University Nanoconjugates able to cross the blood-brain barrier
JP6234370B2 (ja) 2011-10-11 2017-11-22 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. 神経変性障害におけるマイクロrna
BR112014009968A2 (pt) 2011-10-25 2017-07-04 Du Pont método para redução do teor de acetato, arabinosidase e/ou ferulato em uma planta, método de modulação da concentração de carboidratos da planta em uma planta transgénica, método para alterar o teor de acetila e de reticulação nos tecidos das plantas, método para a produção de biomassa para a produção de biocombustíveis ou silagem, produto, forragem de planta
CN104093842B (zh) 2011-10-31 2016-12-07 先锋国际良种公司 改善植物耐旱性、氮利用效率和产量
DK2790736T3 (en) 2011-12-12 2018-05-07 Oncoimmunin Inc In vivo delivery of oligonucleotides
WO2013121426A1 (en) 2012-02-13 2013-08-22 Gamida-Cell Ltd. Culturing of mesenchymal stem cells
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
US9783814B2 (en) 2012-03-13 2017-10-10 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
WO2013138309A1 (en) 2012-03-13 2013-09-19 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
PL2825648T3 (pl) 2012-03-15 2019-01-31 Curna, Inc. Leczenie chorób związanych z neurotroficznym czynnikiem pochodzenia mózgowego (bdnf) poprzez zahamowanie naturalnego transkryptu antysensownego względem bdnf
WO2013138662A1 (en) 2012-03-16 2013-09-19 4S3 Bioscience, Inc. Antisense conjugates for decreasing expression of dmpk
WO2013154799A1 (en) 2012-04-09 2013-10-17 Isis Pharmaceuticals, Inc. Tricyclic nucleosides and oligomeric compounds prepared therefrom
EP2850092B1 (en) 2012-04-09 2017-03-01 Ionis Pharmaceuticals, Inc. Tricyclic nucleic acid analogs
EP2839005B1 (en) 2012-04-20 2021-01-06 Aptamir Therapeutics, Inc. Mirna modulators of thermogenesis
WO2013163628A2 (en) 2012-04-27 2013-10-31 Duke University Genetic correction of mutated genes
AU2013262663A1 (en) 2012-05-16 2015-01-22 The General Hospital Corporation D/B/A Massachusetts General Hospital Compositions and methods for modulating gene expression
WO2013173638A1 (en) 2012-05-16 2013-11-21 Rana Therapeutics, Inc. Compositions and methods for modulating smn gene family expression
US10045499B2 (en) 2012-05-24 2018-08-14 Iowa State University Research Foundation, Inc. Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants
WO2013184209A1 (en) 2012-06-04 2013-12-12 Ludwig Institute For Cancer Research Ltd. Mif for use in methods of treating subjects with a neurodegenerative disorder
AR091489A1 (es) 2012-06-19 2015-02-11 Basf Se Plantas que tienen una mayor tolerancia a herbicidas inhibidores de la protoporfirinogeno oxidasa (ppo)
EP2677035A1 (en) 2012-06-22 2013-12-25 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
EP2880161A1 (en) 2012-08-03 2015-06-10 Aptamir Therapeutics, Inc. Cell-specific delivery of mirna modulators for the treatment of obesity and related disorders
EP2885312A4 (en) 2012-08-15 2016-01-20 Isis Pharmaceuticals Inc PROCESS FOR THE PREPARATION OF OLIGOMERIC COMPOUNDS USING MODIFIED STREAMING PROTOCOLS
WO2014027021A1 (en) 2012-08-16 2014-02-20 Vib Vzw Means and methods for altering the lignin pathway in plants
WO2014037735A1 (en) 2012-09-10 2014-03-13 University Of Leicester Atsp1, an e3 ubiquitin ligase, and its use
US9029335B2 (en) 2012-10-16 2015-05-12 Isis Pharmaceuticals, Inc. Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
AU2013336237A1 (en) 2012-10-22 2015-06-11 Sabag-Rfa Ltd A system for delivering therapeutic agents into living cells and cells nuclei
CA2889557A1 (en) 2012-11-20 2014-05-30 Pioneer Hi-Bred International., Inc. Engineering plants for efficient uptake and utilization of urea to improve crop production
US20150351390A1 (en) 2012-12-21 2015-12-10 Pioneer Hi-Bred International, Inc. Compositions and methods for auxin-analog conjugation
EP2754715A1 (en) 2013-01-11 2014-07-16 Consejo Superior De Investigaciones Científicas (CSIC) Stress tolerant plants
WO2014118018A1 (en) 2013-01-29 2014-08-07 Basf Plant Science Company Gmbh Fungal resistant plants expressing ein2
BR112015017345A2 (pt) 2013-01-29 2017-11-21 Basf Plant Science Co Gmbh método para aumentar a resistência aos fungos em uma planta, construção de vetor recombinante, planta transgênica, método para produção de planta transgência, uso de qualquer um dos ácidos nucleicos exógenos, parte que pode ser colhida de uma planta transgênica, produto derivado de uma planta, método para produção de um produto e método para cultivar uma planta resistente a fungos
US10462994B2 (en) 2013-01-29 2019-11-05 Basf Plant Science Company Gmbh Fungal resistant plants expressing HCP7
WO2014121436A1 (en) 2013-02-05 2014-08-14 Plant Bioscience Limited Transgenic plants
CA2900005A1 (en) 2013-03-08 2014-09-12 Basf Plant Science Company Gmbh Fungal resistant plants expressing mybtf
US20160002648A1 (en) 2013-03-11 2016-01-07 Mei Guo Genes for improving nutrient uptake and abiotic stress tolerance in plants
US9803214B2 (en) 2013-03-12 2017-10-31 Pioneer Hi-Bred International, Inc. Breeding pair of wheat plants comprising an MS45 promoter inverted repeat that confers male sterility and a construct that restores fertility
UA123532C2 (uk) 2013-03-12 2021-04-21 Е. І. Дю Пон Де Немур Енд Компані Спосіб ідентифікації варіантного сайта розпізнавання для сконструйованого засобу, що рідко розщеплює, для індукції двониткового розриву
US20160017360A1 (en) 2013-03-13 2016-01-21 Pioneer Hi-Bred International, Inc. Functional expression of bacterial major facilitator superfamily mfs gene in maize to improve agronomic traits and grain yield
US20160010101A1 (en) 2013-03-13 2016-01-14 Pioneer Hi-Bred International, Inc. Enhanced nitrate uptake and nitrate translocation by over- expressing maize functional low-affinity nitrate transporters in transgenic maize
CN114703210A (zh) 2013-03-14 2022-07-05 希博斯美国有限公司 突变的丙二烯氧合酶2(aos2)基因
CN105143248A (zh) 2013-03-14 2015-12-09 先锋国际良种公司 玉蜀黍胁迫相关转录因子18及其用途
PL2966984T3 (pl) 2013-03-15 2022-06-13 Cibus Us Llc Ukierunkowana modyfikacja genu z użyciem naprawy genu, w której pośredniczy oligonukleotyd
US9957515B2 (en) 2013-03-15 2018-05-01 Cibus Us Llc Methods and compositions for targeted gene modification
EA201591445A1 (ru) * 2013-03-15 2016-03-31 Сибас Юс Ллс Способы и композиции для повышения эффективности направленной модификации генов с применением опосредованной олигонуклеотидами репарации генов
US20160017350A1 (en) 2013-03-15 2016-01-21 Pioneer Hi-Bred International, Inc. Compositions and methods of use of acc oxidase polynucleotides and polypeptides
BR112015023703A2 (pt) 2013-03-15 2017-07-18 Pioneer Hi Bred Int modulação de expressão de deaminase de acc
WO2014147249A1 (en) 2013-03-21 2014-09-25 Vib Vzw Means and methods for the reduction of photorespiration in crops
MX2015015239A (es) 2013-05-01 2016-10-03 Ionis Pharmaceuticals Inc Composiciones y metodos.
WO2014197938A1 (en) 2013-06-13 2014-12-18 Antisense Therapeutics Ltd Combination therapy
EP2816115A1 (en) 2013-06-17 2014-12-24 BASF Plant Science Company GmbH Plants having one or more enhanced yield-related traits and a method for making the same
WO2014207743A2 (en) 2013-06-24 2014-12-31 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
US10570409B2 (en) 2013-07-09 2020-02-25 Board Of Trustees Of Michigan State University Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto
US11459579B2 (en) 2013-07-09 2022-10-04 Board Of Trustees Of Michigan State University Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto
US11162096B2 (en) 2013-10-14 2021-11-02 Ionis Pharmaceuticals, Inc Methods for modulating expression of C9ORF72 antisense transcript
CA2844640A1 (en) 2013-12-06 2015-06-06 The University Of British Columbia Method for treatment of castration-resistant prostate cancer
EP2896698A1 (en) 2014-01-17 2015-07-22 BASF Plant Science Company GmbH Plants having one or more enhanced yield-related traits and a method for making the same
US20170166920A1 (en) 2014-01-30 2017-06-15 Two Blades Foundation Plants with enhanced resistance to phytophthora
JP6920818B2 (ja) 2014-01-31 2021-08-18 テンプル ユニバーシティー オブ ザ コモンウェルス システム オブ ハイアー エデュケーション 心不全の治療のための標的としてのbag3
AU2015214264B2 (en) 2014-02-04 2018-12-20 Curis, Inc. Mutant Smoothened and methods of using the same
KR102450868B1 (ko) 2014-03-14 2022-10-06 시버스 유에스 엘엘씨 올리고뉴클레오타이드 매개 유전자 보수를 사용한 표적화된 유전자 변형의 효율을 증가시키기 위한 방법 및 조성물
EP3119789B1 (en) 2014-03-17 2020-04-22 Ionis Pharmaceuticals, Inc. Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
CA2942340A1 (en) 2014-03-19 2015-09-24 Ionis Pharmaceuticals, Inc. Compositions for modulating ataxin 2 expression
US10006027B2 (en) 2014-03-19 2018-06-26 Ionis Pharmaceuticals, Inc. Methods for modulating Ataxin 2 expression
KR20220077933A (ko) 2014-04-01 2022-06-09 바이오젠 엠에이 인코포레이티드 Sod-1 발현을 조절하기 위한 조성물
WO2015150465A2 (en) 2014-04-03 2015-10-08 Basf Se Plants having increased tolerance to herbicides
US10221416B2 (en) 2014-04-24 2019-03-05 Ionis Pharmaceuticals, Inc. Oligomeric compounds comprising alpha-beta-constrained nucleic acid
RS59182B1 (sr) 2014-05-01 2019-10-31 Ionis Pharmaceuticals Inc Kompozicije i postupci za modulaciju ekspresije faktora b komplementa
WO2015171603A1 (en) 2014-05-06 2015-11-12 Two Blades Foundation Methods for producing plants with enhanced resistance to oomycete pathogens
KR102290205B1 (ko) 2014-06-04 2021-08-20 엑시큐어, 인크. 예방 또는 치료 용도를 위한 리포솜성 구형 핵산에 의한 면역 조절인자의 다가 전달
EP3155100B1 (en) 2014-06-10 2021-12-22 Erasmus University Medical Center Rotterdam Antisense oligonucleotides useful in treatment of pompe disease
EP3161159B1 (en) 2014-06-25 2020-08-05 The General Hospital Corporation Targeting human satellite ii (hsatii)
CA2985344A1 (en) 2014-06-26 2015-12-30 The Trustees Of Columbia University In The City Of New York Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
EP3166964A1 (en) 2014-07-08 2017-05-17 Vib Vzw Means and methods to increase plant yield
MX2017000555A (es) 2014-07-14 2017-08-10 Univ Washington State Desactivacion de nanos que produce ablacion de celulas de linea germinal.
WO2016033424A1 (en) 2014-08-29 2016-03-03 Genzyme Corporation Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b
US10436802B2 (en) 2014-09-12 2019-10-08 Biogen Ma Inc. Methods for treating spinal muscular atrophy
EP3663403A1 (en) 2014-09-26 2020-06-10 University of Massachusetts Rna-modulating agents
EP3739053B1 (en) 2014-10-06 2023-08-30 Altria Client Services LLC Genetic control of axillary bud growth in tobacco plants
SG11201703939XA (en) 2014-11-17 2017-06-29 Moerae Matrix Inc Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
KR20170078843A (ko) 2014-11-21 2017-07-07 노오쓰웨스턴 유니버시티 구형 핵산 나노입자 접합체의 서열 특이적 세포 흡수
WO2016100309A1 (en) 2014-12-16 2016-06-23 Pioneer Hi-Bred International, Inc. Restoration of male fertility in wheat
US9688707B2 (en) 2014-12-30 2017-06-27 Ionis Pharmaceuticals, Inc. Bicyclic morpholino compounds and oligomeric compounds prepared therefrom
WO2016112132A1 (en) 2015-01-06 2016-07-14 Ionis Pharmaceuticals, Inc. Compositions for modulating expression of c9orf72 antisense transcript
US10538763B2 (en) 2015-01-16 2020-01-21 Ionis Pharmaceuticals, Inc. Compounds and methods for modulation of DUX4
JP7040941B2 (ja) 2015-01-21 2022-03-23 ビーエーエスエフ ソシエタス・ヨーロピア 除草剤耐性の増加した植物
WO2016124920A1 (en) 2015-02-03 2016-08-11 The Institute Of Genetics And Developmental Biology Rice plants with altered seed phenotype and quality
US10793868B2 (en) 2015-02-03 2020-10-06 Institute Of Genetics And Developmental Biology Chinese Academy Of Sciences Plants with increased seed size
US10570412B2 (en) 2015-02-04 2020-02-25 Basf Plant Science Company Gmbh Method of increasing resistance against soybean rust in transgenic plants by increasing the scopoletin content
GB201501941D0 (en) 2015-02-05 2015-03-25 British American Tobacco Co Method
JP6929791B2 (ja) 2015-02-09 2021-09-01 デューク ユニバーシティ エピゲノム編集のための組成物および方法
US11248234B2 (en) 2015-02-11 2022-02-15 Basf Se Herbicide-resistant hydroxyphenylpyruvate dioxygenases
GB201502409D0 (en) 2015-02-13 2015-04-01 British American Tobacco Co Method
US11129844B2 (en) 2015-03-03 2021-09-28 Ionis Pharmaceuticals, Inc. Compositions and methods for modulating MECP2 expression
CA2978941A1 (en) 2015-03-12 2016-09-15 Moerae Matrix, Inc. Use of mk2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
CA2978228A1 (en) 2015-03-18 2016-09-22 Basf Se Recombinant microorganism for improved production of fine chemicals
EP3283502A4 (en) 2015-04-07 2019-04-03 The General Hospital Corporation METHODS FOR REACTIVATION OF GENES ON INACTIVE X CHROMOSOME
US10407678B2 (en) 2015-04-16 2019-09-10 Ionis Pharmaceuticals, Inc. Compositions for modulating expression of C9ORF72 antisense transcript
CN107709564B (zh) 2015-05-09 2021-11-02 双刃基金会 来自少花龙葵的抗晚疫病基因及使用方法
CN108350040B (zh) 2015-06-04 2022-03-25 巴斯夫欧洲公司 用于精细化学品的改进生产的重组微生物
MX2017016109A (es) 2015-06-12 2018-04-20 Basf Se Microorganismo recombinante para la produccion mejorada de productos quimicos finos.
CA2990852A1 (en) 2015-06-26 2016-12-29 Beth Israel Deaconess Medical Center, Inc. Cancer therapy targeting tetraspanin 33 (tspan33) in myeloid derived suppressor cells
AU2016287499B2 (en) 2015-06-29 2022-08-04 Caris Science, Inc. Therapeutic oligonucleotides
WO2017019918A1 (en) 2015-07-28 2017-02-02 Caris Science, Inc. Targeted oligonucleotides
PT3353303T (pt) 2015-09-25 2023-10-10 Academisch Ziekenhuis Leiden Composições e métodos para modulação da expressão de ataxina 3
WO2017062790A1 (en) 2015-10-09 2017-04-13 Two Blades Foundation Cold shock protein receptors and methods of use
EP4089175A1 (en) 2015-10-13 2022-11-16 Duke University Genome engineering with type i crispr systems in eukaryotic cells
CA3001979A1 (en) 2015-10-22 2017-04-27 Basf Se Plants having increased tolerance to herbicides
WO2017075670A1 (en) 2015-11-05 2017-05-11 Children's Hospital Los Angeles "mobilizing leukemia cells"
AU2016355178B9 (en) 2015-11-19 2019-05-30 Massachusetts Institute Of Technology Lymphocyte antigen CD5-like (CD5L)-interleukin 12B (p40) heterodimers in immunity
US11058709B1 (en) 2015-12-04 2021-07-13 Ionis Pharmaceuticals, Inc. Methods of treating breast cancer
EP3387127A1 (en) 2015-12-07 2018-10-17 Erasmus University Medical Center Rotterdam Enzymatic replacement therapy and antisense therapy for pompe disease
EP3400300A4 (en) 2016-01-05 2019-08-07 Ionis Pharmaceuticals, Inc. METHODS FOR REDUCING LRRK2 EXPRESSION
EP3411396A1 (en) 2016-02-04 2018-12-12 Curis, Inc. Mutant smoothened and methods of using the same
EA201891629A1 (ru) 2016-02-09 2019-03-29 Сибас Юс Ллс Способы и композиции для повышения эффективности нацеленной модификации генов с применением опосредуемой олигонуклеотидами репарации генов
EP3419665A4 (en) 2016-02-25 2019-10-16 The Brigham and Women's Hospital, Inc. METHODS OF TREATING FIBROSIS BY TARGETING SMOC2
EP3426786A1 (en) 2016-03-11 2019-01-16 Altria Client Services LLC Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers
EP3429690A4 (en) 2016-03-16 2019-10-23 Ionis Pharmaceuticals, Inc. METHOD FOR MODULATING KEAP1
WO2017161168A1 (en) 2016-03-16 2017-09-21 Ionis Pharmaceuticals, Inc. Modulation of dyrk1b expression
EP3430137A4 (en) 2016-03-18 2019-11-06 Caris Science, Inc. OLIGONUCLEOTIDE THONES AND USES THEREOF
EP3436574B1 (en) 2016-03-30 2021-08-25 Basf Se Fermentative production of n-butylacrylate using alcohol acyl transferase enzymes
WO2017184500A1 (en) 2016-04-18 2017-10-26 Bloomsburg University of Pennsylvania Compositions and methods of delivering molecules to plants
CN109072207B (zh) 2016-04-29 2024-05-07 巴斯夫植物科学有限公司 用于修饰靶核酸的改进方法
EP3054014A3 (en) 2016-05-10 2016-11-23 BASF Plant Science Company GmbH Use of a fungicide on transgenic plants
WO2017198859A1 (en) 2016-05-20 2017-11-23 BASF Agro B.V. Dual transit peptides for targeting polypeptides
WO2017202774A1 (en) 2016-05-24 2017-11-30 Basf Se Method for controlling ppo resistant weeds
CA3025486A1 (en) 2016-05-25 2017-11-30 Caris Science, Inc. Oligonucleotide probes and uses thereof
US11174493B2 (en) 2016-05-26 2021-11-16 Nunhems B.V. Seedless fruit producing plants
CA3023514A1 (en) 2016-06-17 2017-12-21 Ionis Pharmaceuticals, Inc. Modulation of gys1 expression
CN109642224A (zh) 2016-06-22 2019-04-16 北卡罗莱纳州立大学 用于增加植物中的氮使用效率和/或氮利用效率的方法
EP3481430A4 (en) 2016-07-11 2020-04-01 Translate Bio Ma, Inc. NUCLEIC ACID CONJUGATES AND USES THEREOF
CN109688807B (zh) 2016-07-15 2023-04-28 巴斯夫欧洲公司 具有增加的除草剂耐受性的植物
BR112019001483A2 (pt) 2016-07-27 2019-09-10 Basf Agro Bv método para controlar a vegetação indesejada em um local de cultivo de plantas
WO2018019845A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
CA3030354A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
NL2017294B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Natural cryptic exon removal by pairs of antisense oligonucleotides.
EP3278667A1 (en) 2016-08-05 2018-02-07 Basf Se Method for controlling ppo-inhibitor resistant weeds
WO2018024695A1 (en) 2016-08-05 2018-02-08 Basf Se Method for controlling ppo resistant weeds
NL2017295B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Antisense oligomeric compound for Pompe disease
US20210368793A1 (en) 2016-08-05 2021-12-02 Basf Se Method for Controlling PPO Resistant Weeds
WO2018029031A1 (en) 2016-08-09 2018-02-15 Basf Se Method for controlling ppo resistant weeds
EP3281523A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
WO2018029030A1 (en) 2016-08-09 2018-02-15 Basf Se Method for controlling ppo resistant weeds
EP3281525A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
WO2018029029A1 (en) 2016-08-09 2018-02-15 Basf Se Method for controlling ppo resistant weeds
EP3281524A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
EP3497213B1 (en) 2016-08-09 2023-10-18 Vib Vzw Cellulose synthase inhibitors and mutant plants
US11400161B2 (en) 2016-10-06 2022-08-02 Ionis Pharmaceuticals, Inc. Method of conjugating oligomeric compounds
WO2018067985A1 (en) 2016-10-07 2018-04-12 Altria Client Services Llc Composition and methods for producing tobacco plants and products having reduced tobacco-specific nitrosamines (tsnas)
CA3037046A1 (en) 2016-10-31 2018-05-03 University Of Massachusetts Targeting microrna-101-3p in cancer therapy
JOP20190104A1 (ar) 2016-11-10 2019-05-07 Ionis Pharmaceuticals Inc مركبات وطرق لتقليل التعبير عن atxn3
WO2018102745A1 (en) 2016-12-02 2018-06-07 Cold Spring Harbor Laboratory Modulation of lnc05 expression
EP3555299A1 (en) 2016-12-16 2019-10-23 Two Blades Foundation Late blight resistance genes and methods of use
US11879132B2 (en) 2016-12-20 2024-01-23 BASF Agro B.V. Plants having increased tolerance to herbicides
BR112019013211A2 (pt) 2016-12-27 2019-12-10 Inbiose N.V. síntese in vivo de compostos sialilados
WO2018140214A1 (en) 2017-01-24 2018-08-02 Pioneer Hi-Bred International, Inc. Nematicidal protein from pseudomonas
WO2018146481A1 (en) 2017-02-09 2018-08-16 Fujian Agriculture And Forestry University Expression of a phosphate transporter for improving plant yield
WO2018165564A1 (en) 2017-03-09 2018-09-13 Ionis Pharmaceuticals, Inc. Morpholino modified oligomeric compounds
AU2018256435A1 (en) 2017-04-20 2019-11-07 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
US20200384115A1 (en) 2017-04-21 2020-12-10 The Broad Institute , Inc. Targeted delivery to beta cells
US11445692B2 (en) 2017-05-15 2022-09-20 Equi-Nom Ltd. Quantitative trait loci (QTL) associated with shatter resistant capsules in sesame and uses thereof
CN111542608A (zh) 2017-07-28 2020-08-14 双刃基金会 马铃薯y病毒抗性基因及使用方法
US11197884B2 (en) 2017-08-18 2021-12-14 Ionis Pharmaceuticals, Inc. Modulation of the notch signaling pathway for treatment of respiratory disorders
WO2019051173A1 (en) 2017-09-08 2019-03-14 Ionis Pharmaceuticals, Inc. MODULATORS OF SMAD7 EXPRESSION
US11104912B2 (en) 2017-09-11 2021-08-31 Altria Client Services Llc Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers
US11999953B2 (en) 2017-09-13 2024-06-04 The Children's Medical Center Corporation Compositions and methods for treating transposon associated diseases
TWI809004B (zh) 2017-11-09 2023-07-21 美商Ionis製藥公司 用於降低snca表現之化合物及方法
WO2019108619A1 (en) 2017-11-28 2019-06-06 Two Blades Foundation Methods and compositions for enhancing the disease resistance of plants
BR112020010778A2 (pt) 2017-11-29 2020-11-24 Basf Se método para controlar a vegetação indesejada em um local de cultivo de plantas
WO2019125804A1 (en) 2017-12-20 2019-06-27 Basf Se Nucleases and methods for making and using them
WO2019126641A2 (en) 2017-12-21 2019-06-27 Ionis Pharmaceuticals, Inc. Modulation of frataxin expression
US11034969B2 (en) 2017-12-22 2021-06-15 Altria Client Services Llc Plant comprising recombinant polynucleotides encoding a pigment regulatory transcription factor with a tissue-preferred promoter
CN107868123B (zh) 2017-12-25 2020-05-12 中国农业科学院作物科学研究所 一种同时提高植物产量和抗性的基因及其应用
US11359208B2 (en) 2018-01-09 2022-06-14 Cibus Us Llc Shatterproof genes and mutations
WO2019140351A1 (en) 2018-01-12 2019-07-18 Two Blades Foundation Stem rust resistance genes and methods of use
MX2020007369A (es) 2018-01-15 2020-10-28 Ionis Pharmaceuticals Inc Moduladores de la expresion de dnm2.
EP3740578A4 (en) 2018-01-17 2021-12-29 Basf Se Plants having increased tolerance to herbicides
BR112020014242A2 (pt) 2018-02-14 2020-12-15 Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences Métodos de aumento da eficiência de uso de nutriente
TWI840345B (zh) 2018-03-02 2024-05-01 美商Ionis製藥公司 Irf4表現之調節劑
US11732260B2 (en) 2018-03-02 2023-08-22 Ionis Pharmaceuticals, Inc. Compounds and methods for the modulation of amyloid-β precursor protein
US11661601B2 (en) 2018-03-22 2023-05-30 Ionis Pharmaceuticals, Inc. Methods for modulating FMR1 expression
WO2019186514A2 (en) 2018-03-30 2019-10-03 Rheinische Friedrich-Wilhelms-Universitat Bonn Aptamers for targeted activaton of t cell-mediated immunity
EP3773017B1 (en) 2018-04-03 2022-06-08 Altria Client Services LLC Composition and methods for producing tobacco plants and products having increased phenylalanine and reduced tobacco-specific nitrosamines (tsnas)
EP3772928A4 (en) 2018-04-06 2021-12-29 Children's Medical Center Corporation Compositions and methods for somatic cell reprogramming and modulating imprinting
CN112041440A (zh) 2018-04-11 2020-12-04 Ionis制药公司 Ezh2表达的调节剂
CN112368375A (zh) 2018-04-26 2021-02-12 巴斯夫欧洲公司 脂肪酶
EP3788145A1 (en) 2018-05-03 2021-03-10 Basf Se Amylase enzymes
CN112041446B (zh) 2018-05-09 2022-08-30 Ionis制药公司 用于减少fxi表达的化合物和方法
SG11202010215TA (en) 2018-05-09 2020-11-27 Ionis Pharmaceuticals Inc Compounds and methods for reducing atxn3 expression
WO2019219933A1 (en) 2018-05-17 2019-11-21 Vib Vzw An engineered combinatorial module of transcription factors to boost production of monoterpenoid indole alkaloids
AU2019287635A1 (en) 2018-06-14 2020-12-17 Ionis Pharmaceuticals, Inc. Compounds and methods for increasing STMN2 expression
US11291176B2 (en) 2018-06-15 2022-04-05 Nunhems B.V. Seedless watermelon plants comprising modifications in an ABC transporter gene
TWI833770B (zh) 2018-06-27 2024-03-01 美商Ionis製藥公司 用於減少 lrrk2 表現之化合物及方法
CA3105394A1 (en) 2018-07-02 2020-01-09 Aptamir Therapeutics, Inc. Targeted delivery of therapeutic agents to human adipocytes
MX2021000922A (es) 2018-07-25 2021-03-31 Ionis Pharmaceuticals Inc Compuestos y metodos para reducir la expresion de la atxn2.
WO2020047229A1 (en) 2018-08-29 2020-03-05 University Of Massachusetts Inhibition of protein kinases to treat friedreich ataxia
CA3110651A1 (en) 2018-09-07 2020-03-12 Basf Plant Science Company Gmbh Improved method for the production of high levels of pufa in plants
WO2020049157A1 (en) 2018-09-07 2020-03-12 Basf Plant Science Company Gmbh Improved method for the production of high levels of pufa in plants
AU2019334672A1 (en) 2018-09-07 2021-03-25 Basf Plant Science Company Gmbh Improved method for the production of high levels of PUFA in plants
EP3867391A1 (en) 2018-10-18 2021-08-25 Basf Se Method for the production of acrylic acid or salts thereof
TW202028222A (zh) 2018-11-14 2020-08-01 美商Ionis製藥公司 Foxp3表現之調節劑
PE20211869A1 (es) 2018-11-15 2021-09-21 Ionis Pharmaceuticals Inc Moduladores de la expresion de irf5
WO2020127975A1 (en) 2018-12-20 2020-06-25 Basf Plant Science Company Gmbh Native delivery of biomolecules into plant cells using ionic complexes with cell-penetrating peptides
US20220017931A1 (en) 2019-01-22 2022-01-20 Basf Se Method for production of 4-cyano benzoic acid or salts thereof
EP3914069A1 (en) 2019-01-24 2021-12-01 Altria Client Services LLC Tobacco plants comprising reduced nicotine and reduced tobacco specific nitrosamines
WO2020160453A1 (en) 2019-01-31 2020-08-06 Ionis Pharmaceuticals, Inc. Modulators of yap1 expression
WO2020171889A1 (en) 2019-02-19 2020-08-27 University Of Rochester Blocking lipid accumulation or inflammation in thyroid eye disease
GB201902253D0 (en) 2019-02-19 2019-04-03 Univ Court Univ Of Glasgow Methods for optogenetic manipulation of stomatal function
AU2020227824A1 (en) 2019-02-27 2021-08-26 Ionis Pharmaceuticals, Inc. Modulators of MALAT1 expression
EP3938504A1 (en) 2019-03-11 2022-01-19 Basf Se Amylases and methods for making and using them
CA3133614A1 (en) 2019-03-14 2020-09-17 Rothamsted Research Limited Genetically modified plants with enhanced drought tolerance
US20220162576A1 (en) 2019-03-25 2022-05-26 Basf Se Amylase enzymes
WO2020193532A1 (en) 2019-03-25 2020-10-01 Basf Se Cleaning composition having amylase enzymes
EP3947664A2 (en) 2019-03-25 2022-02-09 Basf Se Amylase enzymes
AU2020253821A1 (en) 2019-03-29 2021-10-28 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating UBE3A-ATS
AU2020274594A1 (en) 2019-05-10 2022-01-20 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
US20220251595A1 (en) 2019-06-27 2022-08-11 Two Blades Foundation Engineered atrlp23 pattern recognition receptors and methods of use
CN114026238A (zh) 2019-06-27 2022-02-08 巴斯夫植物科学有限公司 用于转化真菌孢子的方法
WO2021011348A1 (en) 2019-07-12 2021-01-21 The Regents Of The University Of California Plants with enhanced resistance to bacterial pathogens
EP3956450A4 (en) 2019-07-26 2022-11-16 Ionis Pharmaceuticals, Inc. COMPOUNDS AND METHODS FOR MODULATION OF GFAP
EP4013767A4 (en) 2019-08-15 2023-10-25 Ionis Pharmaceuticals, Inc. COMPOUND-MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF
EP4017974A1 (en) 2019-08-22 2022-06-29 Basf Se Amylase variants
US20230203515A1 (en) 2019-09-12 2023-06-29 Basf Se Regulatory Nucleic Acid Molecules for Enhancing Gene Expression in Plants
WO2021058691A1 (en) 2019-09-26 2021-04-01 Basf Se Method for the production of beta-alanine or salts thereof
WO2021069387A1 (en) 2019-10-07 2021-04-15 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
EP4069852A1 (en) 2019-12-03 2022-10-12 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
AU2020404580A1 (en) 2019-12-16 2022-06-23 BASF Agricultural Solutions Seed US LLC Improved genome editing using paired nickases
WO2021121921A1 (en) 2019-12-16 2021-06-24 BASF Agricultural Solutions Seed US LLC Codon-optimized cas9 endonuclease encoding polynucleotide
CN114846144A (zh) 2019-12-16 2022-08-02 巴斯夫农业种子解决方案美国有限责任公司 将dna或突变精确引入小麦基因组
JOP20220201A1 (ar) 2020-02-28 2023-01-30 Ionis Pharmaceuticals Inc مركبات وطرق لتعديل smn2
WO2021175756A1 (en) 2020-03-04 2021-09-10 Basf Se Shuttle vector for expression in e. coli and bacilli
KR20220150328A (ko) 2020-03-04 2022-11-10 바스프 에스이 낮은 내지 중간 발현을 부여하는 구성적 박테리아 프로모터를 생산하는 방법
AU2021264010A1 (en) 2020-05-01 2022-12-08 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating ATXN1
CA3172001A1 (en) 2020-05-15 2021-11-18 Basf Se Improved method for the production of isoprenoids
JP2023532518A (ja) 2020-06-29 2023-07-28 アイオーニス ファーマシューティカルズ, インコーポレーテッド Plp1を調節するための化合物及び方法
US11730133B2 (en) 2020-10-21 2023-08-22 Equi-Nom Ltd High yield sesame
EP4136092B1 (en) 2020-11-18 2024-07-31 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating angiotensinogen expression
JP2023554346A (ja) 2020-12-18 2023-12-27 アイオーニス ファーマシューティカルズ, インコーポレーテッド 第xii因子を調節するための化合物及び方法
JP2024518825A (ja) 2021-05-11 2024-05-07 トゥー・ブレーズ・ファウンデーション 疾病耐性に関する機能検査のための植物疾病耐性遺伝子のライブラリーを調製する方法
MX2023015230A (es) 2021-06-18 2024-01-18 Ionis Pharmaceuticals Inc Compuestos y metodos para reducir la expresion de ifnar1.
CN118019447A (zh) 2021-08-06 2024-05-10 Kws蔬菜有限责任公司 菠菜对霜霉病的持久抗性
WO2023031161A1 (en) 2021-09-03 2023-03-09 BASF Agricultural Solutions Seed US LLC Plants having increased tolerance to herbicides
US11395470B1 (en) 2021-09-14 2022-07-26 Equi-Nom Ltd. Sesame with high oil content and/or high yield
WO2023043220A1 (ko) 2021-09-16 2023-03-23 주식회사 큐마인 Wfdc2의 발현을 조절하는 안티센스 화합물
EP4408859A1 (en) 2021-09-30 2024-08-07 Two Blades Foundation Plant disease resistance genes against stem rust and methods of use
WO2023067192A1 (en) 2021-10-21 2023-04-27 Consejo Superior De Investigaciones Cientificas (Csic) Methods for improving abiotic stress resistance
WO2023105244A1 (en) 2021-12-10 2023-06-15 Pig Improvement Company Uk Limited Editing tmprss2/4 for disease resistance in livestock
WO2023118136A1 (en) 2021-12-22 2023-06-29 BASF Agricultural Solutions Seed US LLC Improved screening method for genome edited events
WO2023131616A1 (en) 2022-01-05 2023-07-13 Vib Vzw Means and methods to increase abiotic stress tolerance in plants
WO2023131637A1 (en) 2022-01-06 2023-07-13 Vib Vzw Improved silage grasses
WO2023144199A1 (en) 2022-01-26 2023-08-03 Vib Vzw Plants having reduced levels of bitter taste metabolites
WO2024026474A1 (en) 2022-07-29 2024-02-01 Regeneron Pharmaceuticals, Inc. Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
WO2024044352A1 (en) 2022-08-26 2024-02-29 The General Hospital Corporation Methods and compositions for prognosis and treatment of dilated cardiomyopathy and heart failure
WO2024083579A1 (en) 2022-10-20 2024-04-25 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
WO2024089011A1 (en) 2022-10-26 2024-05-02 BASF Agricultural Solutions Seed US LLC Excision of recombinant dna from the genome of plant cells
WO2024094678A2 (en) 2022-11-02 2024-05-10 Basf Se Improved method for the production of natural vanillin
WO2024098002A1 (en) 2022-11-04 2024-05-10 Regeneron Pharmaceuticals, Inc. Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
US20240173426A1 (en) 2022-11-14 2024-05-30 Regeneron Pharmaceuticals, Inc. Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
WO2024126113A1 (en) 2022-12-12 2024-06-20 BASF Agricultural Solutions Seed US LLC Plants having increased tolerance to herbicides
WO2024132947A1 (en) 2022-12-19 2024-06-27 Basf Se New cellulase promoters for fungal protein production
WO2024156593A1 (en) 2023-01-27 2024-08-02 Basf Se New genomic integration site for fungal protein and fine chemicals production

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503151A (en) * 1980-12-10 1985-03-05 Research Corporation Recombinant cDNA construction method and hybrid nucleotides useful in cloning
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4882279A (en) * 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
EP0260032B1 (en) * 1986-09-08 1994-01-26 Ajinomoto Co., Inc. Compounds for the cleavage at a specific position of RNA, oligomers employed for the formation of said compounds, and starting materials for the synthesis of said oligomers
US4950599A (en) * 1987-01-29 1990-08-21 Wolf Bertling Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments
WO1990014092A1 (en) * 1989-05-18 1990-11-29 Cell Genesys, Inc. Single-strand site-directed modification of mammalian genes in vivo
CA2128862C (en) * 1992-02-11 2008-05-20 Jonathan G. Seidman Homogenotization of gene-targeting events
CA2118513A1 (en) * 1992-04-24 1993-11-11 David A. Zarling In vivo homologous sequence targeting in eukaryotic cells
WO1994004032A1 (en) * 1992-08-21 1994-03-03 The Regents Of The University Of California Composition and method for altering dna sequences by homologous recombination
JPH08510900A (ja) * 1993-03-31 1996-11-19 ハイブライドン インコーポレイテッド 改良された抗インフルエンザ活性を有する修飾オリゴヌクレオチド

Also Published As

Publication number Publication date
AU691550B2 (en) 1998-05-21
GR3034988T3 (en) 2001-03-30
DE733059T1 (de) 1997-08-28
ES2149962T3 (es) 2000-11-16
KR960706500A (ko) 1996-12-09
NZ278490A (en) 1998-03-25
DE69425903D1 (de) 2000-10-19
AU1399595A (en) 1995-06-27
EP0733059B1 (en) 2000-09-13
CN1142829A (zh) 1997-02-12
DE69425903T2 (de) 2001-02-15
EP0733059A4 (en) 1997-05-21
JPH09506511A (ja) 1997-06-30
ATE196311T1 (de) 2000-09-15
CN1215755A (zh) 1999-05-05
PT733059E (pt) 2001-03-30
EP0733059A1 (en) 1996-09-25
JP3585238B2 (ja) 2004-11-04
US5565350A (en) 1996-10-15
US5756325A (en) 1998-05-26
US5871984A (en) 1999-02-16
KR100386337B1 (ko) 2004-03-24
CN1117866C (zh) 2003-08-13
CN1048254C (zh) 2000-01-12
DK0733059T3 (da) 2000-10-16
WO1995015972A1 (en) 1995-06-15

Similar Documents

Publication Publication Date Title
CA2178729A1 (en) Compounds and methods for site-directed mutations in eukaryotic cells
US6010907A (en) Eukaryotic use of non-chimeric mutational vectors
US7053195B1 (en) Locked nucleic acid containing heteropolymers and related methods
US5149797A (en) Method of site-specific alteration of rna and production of encoded polypeptides
WO2019051097A1 (en) RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USING SAME
CN101868542A (zh) 具有改进的经修饰的寡核苷酸的定向核苷酸交换
CA2205075C (en) Reagent and method for inhibition of n-ras expression
JP6084929B2 (ja) Dnaの標的改変
US6921816B2 (en) Chimerical peptide-nucleic acid fragment, process for producing the same and its for appropriately introducing nucleic acids into cell organelles and cells
JP5947309B2 (ja) オリゴヌクレオチドを用いたdnaの標的改変
JP2003531610A (ja) 相同組換えを行う為の方法及び組成物
US7022501B1 (en) Ligation of double-stranded DNAs
EP1533375B1 (en) Method of transferring mutation into target nucleic acid
JP2005118056A (ja) 疾患関連遺伝子の発現を阻害するための方法および試薬
AO et al. Antisense Inhibition of β-Glucuronidase Expression in Preimplantation Mouse Embryos: A Comparison of Transgenes and Oligodeoxynucleotides
KR20050021366A (ko) 표적 핵산내 돌연변이 도입 방법

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
FZDE Discontinued

Effective date: 20071210